ÃÃ ñàíèòàðíûé âðà÷ ÐÔ: Ïîñòàíîâëåíèå îò 27.12.2010 N 177
Óòâåðæäåí 27.12.2010
ÎÁ ÓÒÂÅÐÆÄÅÍÈÈ ÑÀÍÏÈÍ 2.3.2.2804-10 "ÄÎÏÎËÍÅÍÈß È ÈÇÌÅÍÅÍÈß N 22 Ê ÑÀÍÏÈÍ 2.3.2.1078-01 "ÃÈÃÈÅÍÈ×ÅÑÊÈÅ ÒÐÅÁÎÂÀÍÈß ÁÅÇÎÏÀÑÍÎÑÒÈ È ÏÈÙÅÂÎÉ ÖÅÍÍÎÑÒÈ ÏÈÙÅÂÛÕ ÏÐÎÄÓÊÒÎÂ"
Ñêà÷àòü (39,2 Êá)

 

Çàðåãèñòðèðîâàíî â Ìèíþñòå ÐÔ 17 ôåâðàëÿ 2011 ã. N 19879

 

 

ÔÅÄÅÐÀËÜÍÀß ÑËÓÆÁÀ ÏÎ ÍÀÄÇÎÐÓ Â ÑÔÅÐÅ ÇÀÙÈÒÛ

ÏÐÀ ÏÎÒÐÅÁÈÒÅËÅÉ È ÁËÀÃÎÏÎËÓ×Èß ×ÅËÎÂÅÊÀ

 

ÃËÀÂÍÛÉ ÃÎÑÓÄÀÐÑÒÂÅÍÍÛÉ ÑÀÍÈÒÀÐÍÛÉ ÂÐÀ×

ÐÎÑÑÈÉÑÊÎÉ ÔÅÄÅÐÀÖÈÈ

 

ÏÎÑÒÀÍÎÂËÅÍÈÅ

îò 27 äåêàáðÿ 2010 ã. N 177

 

Îá óòâåðæäåíèè ÑàíÏèí 2.3.2.2804-10

"Äîïîëíåíèÿ è èçìåíåíèÿ N 22 ê ÑàíÏèí 2.3.2.1078-01

"Ãèãèåíè÷åñêèå òðåáîâàíèÿ áåçîïàñíîñòè è ïèùåâîé

öåííîñòè ïèùåâûõ ïðîäóêòîâ"

 

 ñîîòâåòñòâèè ñ Ôåäåðàëüíûì çàêîíîì îò 30.03.1999 N 52-ÔÇ "Î ñàíèòàðíî-ýïèäåìèîëîãè÷åñêîì áëàãîïîëó÷èè íàñåëåíèÿ" (Ñîáðàíèå çàêîíîäàòåëüñòâà Ðîññèéñêîé Ôåäåðàöèè, 1999, N 14, ñò. 1650; 2002, N 1 (÷. I), ñò. 2; 2003, N 2, ñò. 167; 2003, N 27 (÷. I), ñò. 2700; 2004, N 35, ñò. 3607; 2005, N 19, ñò. 1752; 2006, N 1, ñò. 10; 2006, N 52 (÷. I), ñò. 5498; 2007, N 1 (÷. I), ñò. 21; 2007, N 1 (÷. I), ñò. 29; 2007, N 27, ñò. 3213; 2007, N 46, ñò. 5554; 2007, N 49, ñò. 6070; 2008, N 24, ñò. 2801; 2008, N 29 (÷. I), ñò. 3418; 2008, N 30 (÷. II), ñò. 3616; 2008, N 44, ñò. 4984; 2008, N 52 (÷. I), ñò. 6223; 2009, N 1, ñò. 17; 2010, N 40, ñò. 4969) è Ïîñòàíîâëåíèåì Ïðàâèòåëüñòâà Ðîññèéñêîé Ôåäåðàöèè îò 24.07.2000 N 554 "Îá óòâåðæäåíèè Ïîëîæåíèÿ î ãîñóäàðñòâåííîé ñàíèòàðíî-ýïèäåìèîëîãè÷åñêîé ñëóæáå Ðîññèéñêîé Ôåäåðàöèè è Ïîëîæåíèÿ î ãîñóäàðñòâåííîì ñàíèòàðíî-ýïèäåìèîëîãè÷åñêîì íîðìèðîâàíèè" (Ñîáðàíèå çàêîíîäàòåëüñòâà Ðîññèéñêîé Ôåäåðàöèè, 2000, N 31, ñò. 3295; 2004, N 8, ñò. 663; 2004, N 47, ñò. 4666; 2005, N 39, ñò. 3953) ïîñòàíîâëÿþ:

Óòâåðäèòü ÑàíÏèÍ 2.3.2.2804-10 "Äîïîëíåíèÿ è èçìåíåíèÿ N 22 ê ñàíèòàðíî-ýïèäåìèîëîãè÷åñêèì ïðàâèëàì è íîðìàòèâàì ÑàíÏèÍ 2.3.2.1078-01 "Ãèãèåíè÷åñêèå òðåáîâàíèÿ áåçîïàñíîñòè è ïèùåâîé öåííîñòè ïèùåâûõ ïðîäóêòîâ", óòâåðæäåííûì Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè, Ïåðâîãî çàìåñòèòåëÿ Ìèíèñòðà çäðàâîîõðàíåíèÿ Ðîññèéñêîé Ôåäåðàöèè îò 14.11.2001 N 36 (çàðåãèñòðèðîâàíû â Ìèíþñòå Ðîññèè 22.03.2002, ðåãèñòðàöèîííûé íîìåð 3326), ñ èçìåíåíèÿìè è äîïîëíåíèÿìè, âíåñåííûìè Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè, Ïåðâîãî çàìåñòèòåëÿ Ìèíèñòðà çäðàâîîõðàíåíèÿ Ðîññèéñêîé Ôåäåðàöèè îò 31.05.2002 N 18 "Î âíåñåíèè èçìåíåíèé â Ïîñòàíîâëåíèå Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè, Ïåðâîãî çàìåñòèòåëÿ Ìèíèñòðà çäðàâîîõðàíåíèÿ Ðîññèéñêîé Ôåäåðàöèè îò 14.11.2001 N 36" (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 04.06.2002, ðåãèñòðàöèîííûé íîìåð 3499), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè, Ïåðâîãî çàìåñòèòåëÿ Ìèíèñòðà çäðàâîîõðàíåíèÿ Ðîññèéñêîé Ôåäåðàöèè îò 15.04.2003 N 41 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.1280-03" - äîïîëíåíèÿ è èçìåíåíèÿ N 2 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 29.05.2003, ðåãèñòðàöèîííûé íîìåð 4603), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 25 èþíÿ 2007 ã. N 42 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2227-07" - äîïîëíåíèÿ è èçìåíåíèÿ N 5 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 16.07.2007, ðåãèñòðàöèîííûé íîìåð 9852), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 18.02.2008 N 13 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2340-08" - äîïîëíåíèÿ è èçìåíåíèÿ N 6 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 11.03.2008, ðåãèñòðàöèîííûé íîìåð 11311), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 21.04.2008 N 26 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2354-08" - äîïîëíåíèÿ è èçìåíåíèÿ N 8 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 23.05.2008, ðåãèñòðàöèîííûé íîìåð 11741), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 23.05.2008 N 30 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2362-08" - äîïîëíåíèÿ è èçìåíåíèÿ N 9 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 06.06.2008, ðåãèñòðàöèîííûé íîìåð 11805), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 16.07.2008 N 43 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2401-08" - äîïîëíåíèÿ è èçìåíåíèÿ N 10 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 31.07.2008, ðåãèñòðàöèîííûé íîìåð 12059), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 01.10.2008 N 56 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2421-08" - äîïîëíåíèå N 11 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 02.10.2008, ðåãèñòðàöèîííûé íîìåð 12391), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 10.10.2008 N 58 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2422-08" - äîïîëíåíèå N 12 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 27.10.2008, ðåãèñòðàöèîííûé íîìåð 12530), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 11.12.2008 N 69 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2430-08" - èçìåíåíèÿ N 13 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 19.12.2008, ðåãèñòðàöèîííûé íîìåð 12906), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 05.05.2009 N 28 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2509-08" - äîïîëíåíèå N 14 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 29.06.2009, ðåãèñòðàöèîííûé íîìåð 14168), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 08.12.2009 N 73 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2567-09" - äîïîëíåíèÿ è èçìåíåíèÿ N 15 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 24.12.2009, ðåãèñòðàöèîííûé íîìåð 15813), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 27.01.2010 N 6 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2575-10" - èçìåíåíèå N 16 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 10.03.2010, ðåãèñòðàöèîííûé íîìåð 16592), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 21.04.2010 N 27 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2603-10" - äîïîëíåíèå N 17 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 04.05.2010, ðåãèñòðàöèîííûé íîìåð 17097), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 28.06.2010 N 71 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2650-10" - äîïîëíåíèÿ è èçìåíåíèÿ N 18 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 09.08.2010, ðåãèñòðàöèîííûé íîìåð 18097), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 10.08.2010 N 102 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2722-10" - äîïîëíåíèå N 19 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 08.09.2010, ðåãèñòðàöèîííûé íîìåð 18381), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 05.10.2010 N 127 "Î âíåñåíèè èçìåíåíèé â Ïîñòàíîâëåíèå Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 21.04.2010 N 27 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2603-10" (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 09.11.2010, ðåãèñòðàöèîííûé íîìåð N 18913), Ïîñòàíîâëåíèåì Ãëàâíîãî ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à Ðîññèéñêîé Ôåäåðàöèè îò 12.11.2010 N 145 "Îá óòâåðæäåíèè ÑàíÏèÍ 2.3.2.2757-10 - äîïîëíåíèå N 21 ê ÑàíÏèÍ 2.3.2.1078-01 (çàðåãèñòðèðîâàíî â Ìèíþñòå Ðîññèè 21.12.2010, ðåãèñòðàöèîííûé íîìåð 19298) (ïðèëîæåíèå).

 

Ã.Ã.ÎÍÈÙÅÍÊÎ

 

 

 

 

 

Ïðèëîæåíèå

 

Óòâåðæäåíû

Ïîñòàíîâëåíèåì Ãëàâíîãî

ãîñóäàðñòâåííîãî ñàíèòàðíîãî âðà÷à

Ðîññèéñêîé Ôåäåðàöèè

îò 27.12.2010 N 177

 

ÄÎÏÎËÍÅÍÈß È ÈÇÌÅÍÅÍÈß N 22

Ê ÑÀÍÏÈÍ 2.3.2.1078-01

 

ÃÈÃÈÅÍÈ×ÅÑÊÈÅ ÒÐÅÁÎÂÀÍÈß

ÁÅÇÎÏÀÑÍÎÑÒÈ È ÏÈÙÅÂÎÉ ÖÅÍÍÎÑÒÈ ÏÈÙÅÂÛÕ ÏÐÎÄÓÊÒÎÂ

 

Ñàíèòàðíî-ýïèäåìèîëîãè÷åñêèå ïðàâèëà è íîðìàòèâû

ÑàíÏèÍ 2.3.2.2804-10

 

Âíåñòè ñëåäóþùèå äîïîëíåíèÿ â ÑàíÏèÍ 2.3.2.1078-01:

1. Ïóíêò 2.18 äîïîëíèòü àáçàöåì ñëåäóþùåãî ñîäåðæàíèÿ:

- äëÿ îáîãàùåííûõ âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè ïèùåâûõ ïðîäóêòîâ óêàçûâàåòñÿ èíôîðìàöèÿ "îáîãàùåííûé âèòàìèíàìè è/èëè ìèíåðàëüíûìè âåùåñòâàìè ïèùåâîé ïðîäóêò".

2. Ïóíêò 3.14 èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

"3.14.  ïðîäóêòàõ æèâîòíîãî ïðîèñõîæäåíèÿ, â òîì ÷èñëå äëÿ äåòñêîãî ïèòàíèÿ, êîíòðîëèðóþòñÿ îñòàòî÷íûå êîëè÷åñòâà ñòèìóëÿòîðîâ ðîñòà æèâîòíûõ (â òîì ÷èñëå ãîðìîíàëüíûõ ïðåïàðàòîâ), ëåêàðñòâåííûõ ñðåäñòâ (â òîì ÷èñëå àíòèáèîòèêîâ), ïðèìåíÿåìûõ äëÿ öåëåé îòêîðìà, ëå÷åíèÿ è ïðîôèëàêòèêè çàáîëåâàíèé ñêîòà è ïòèöû.

Êîíòðîëèðóåòñÿ ñîäåðæàíèå íàèáîëåå ÷àñòî èñïîëüçóåìûõ â æèâîòíîâîäñòâå è âåòåðèíàðèè êîðìîâûõ è ëå÷åáíûõ àíòèáèîòèêîâ (Ïðèëîæåíèå N 1 íàñòîÿùèõ ñàíèòàðíûõ ïðàâèë):

- áàöèòðàöèíà (áàöèòðàöèíû A, B, C, öèíêáàöèòðàöèí);

- òåòðàöèêëèíîâîé ãðóïïû (òåòðàöèêëèí, îêñèòåòðàöèêëèí, õëîðòåòðàöèêëèí - ñóììà èñõîäíûõ âåùåñòâ è èõ 4-ýïèìåðîâ);

- ãðóïïû ïåíèöèëëèíà (áåíçèëïåíèöèëëèí, ôåíîêñèìåòèëïåíèöèëëèí, àìïèöèëëèí, àìîêñèöèëëèí, ïåíåòàìàò);

- ñòðåïòîìèöèíà;

- ëåâîìèöåòèíà (õëîðàìôåíèêîëà).

3. Ïóíêò 3.15 èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

"3.15. Êîíòðîëü ñîäåðæàíèÿ ñòèìóëÿòîðîâ ðîñòà æèâîòíûõ (â òîì ÷èñëå ãîðìîíàëüíûõ ïðåïàðàòîâ), ëåêàðñòâåííûõ ñðåäñòâ (â òîì ÷èñëå àíòèáèîòèêîâ), ïðèìåíÿåìûõ â æèâîòíîâîäñòâå äëÿ öåëåé îòêîðìà, ëå÷åíèÿ è ïðîôèëàêòèêè çàáîëåâàíèé ñêîòà è ïòèöû, ïðåïàðàòîâ, íå óêàçàííûõ â ï. 3.14, îñíîâûâàåòñÿ íà èíôîðìàöèè, ïðåäñòàâëÿåìîé èçãîòîâèòåëåì (ïîñòàâùèêîì) ïðîäóêöèè îá èñïîëüçîâàííûõ ïðè åå èçãîòîâëåíèè è õðàíåíèè ïðåïàðàòàõ (Ïðèëîæåíèå 21 íàñòîÿùèõ ñàíèòàðíûõ ïðàâèë)".

4. Ïóíêò 3.42 èçëîæèòü â íîâîé ðåäàêöèè:

"3.42. Ïðè îáðàáîòêå ôèëå ðûáû ñ èñïîëüçîâàíèåì ïèùåâûõ äîáàâîê ñîäåðæàíèå âëàãè â íåì ïîñëå ñíÿòèÿ ãëàçóðè íå äîëæíî ïðåâûøàòü 86 ïðîöåíòîâ ìàññû ôèëå ðûáû.

Ìàññà ãëàçóðè, íàíåñåííîé íà ìîðîæåíóþ ðûáíóþ ïðîäóêöèþ, ïðîèçâåäåííóþ èç ðûáû, íå äîëæíà ïðåâûøàòü 5% ìàññû íåòòî, ìàññà ãëàçóðè, íàíåñåííîé íà ïðîäóêöèþ èç ðàêîîáðàçíûõ è ïðîäóêòîâ èõ ïåðåðàáîòêè, íå äîëæíà ïðåâûøàòü 7% ìàññû íåòòî, ìàññà ãëàçóðè, íàíåñåííîé íà ïðîäóêöèþ èç ïðî÷èõ (çà èñêëþ÷åíèåì ðàêîîáðàçíûõ) íåðûáíûõ îáúåêòîâ âîäíîãî ïðîìûñëà (ìîëëþñêè, áåñïîçâîíî÷íûå, ìîðñêèå âîäîðîñëè) çåìíîâîäíûõ, ïðåñìûêàþùèõñÿ è ïðîäóêòîâ èõ ïåðåðàáîòêè, íå äîëæíà ïðåâûøàòü 8% ìàññû íåòòî îò ãëàçèðîâàííîé ìîðîæåíîé ðûáíîé ïðîäóêöèè".

5. Äîïîëíèòü ãëàâîé VIII: "Ãèãèåíè÷åñêèå òðåáîâàíèÿ áåçîïàñíîñòè è ïèùåâîé öåííîñòè ïèùåâûõ ïðîäóêòîâ, îáîãàùåííûõ âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè" ñëåäóþùåãî ñîäåðæàíèÿ:

 

"VIII: Ãèãèåíè÷åñêèå òðåáîâàíèÿ áåçîïàñíîñòè

è ïèùåâîé öåííîñòè ïèùåâûõ ïðîäóêòîâ, îáîãàùåííûõ

âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè

 

8.1. Îñíîâíûå òðåáîâàíèÿ ê îáîãàùåíèþ ïèùåâûõ

ïðîäóêòîâ ìèêðîíóòðèåíòàìè

 

8.1.1. Îáîãàùåíèå ïèùåâûõ ïðîäóêòîâ ïóòåì äîáàâëåíèÿ îäíîãî èëè íåñêîëüêèõ âèòàìèíîâ, ìàêðî- è/èëè ìèêðîýëåìåíòîâ äîëæíî îñóùåñòâëÿòüñÿ â ñîîòâåòñòâèè ñ òðåáîâàíèÿìè:

- îáîãàùåíèþ ïîäëåæàò ïèùåâûå ïðîäóêòû ìàññîâîãî ïîòðåáëåíèÿ, èñïîëüçóåìûå ðåãóëÿðíî è ïîâñåìåñòíî â ïîâñåäíåâíîì ïèòàíèè âçðîñëîãî íàñåëåíèÿ è äåòåé ñòàðøå 3 ëåò, à òàêæå ïèùåâûå ïðîäóêòû, ïîäâåðãàþùèåñÿ ðàôèíèðîâàíèþ è äðóãèì òåõíîëîãè÷åñêèì âîçäåéñòâèÿì, ïðèâîäÿùèì ê ñóùåñòâåííûì ïîòåðÿì âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ;

- äëÿ îáîãàùåíèÿ ïèùåâûõ ïðîäóêòîâ ñëåäóåò èñïîëüçîâàòü òå âèòàìèíû è ìèíåðàëüíûå âåùåñòâà, íåäîñòàòî÷íîå ïîòðåáëåíèå è/èëè ïðèçíàêè äåôèöèòà êîòîðûõ ðåàëüíî îáíàðóæèâàþòñÿ ó íàñåëåíèÿ;

- äîïóñêàåòñÿ èñïîëüçîâàíèå áîëåå ïîëíîãî íàáîðà âèòàìèíîâ, ìàêðî- è ìèêðîýëåìåíòîâ â îáîãàùàþùèõ äîáàâêàõ â âèäå ïðåìèêñîâ;

- ïèùåâûå ïðîäóêòû äîïóñêàåòñÿ îáîãàùàòü âèòàìèíàìè è/èëè ìèíåðàëüíûìè âåùåñòâàìè âíå çàâèñèìîñòè îò òîãî, ñîäåðæàòñÿ ëè îíè â èñõîäíîì ïðîäóêòå;

- êðèòåðèÿìè âûáîðà ïåðå÷íÿ îáîãàùàþùèõ ìèêðîíóòðèåíòîâ, èõ äîç è ôîðì ÿâëÿþòñÿ áåçîïàñíîñòü è ýôôåêòèâíîñòü äëÿ ïîâûøåíèÿ ïèùåâîé öåííîñòè ðàöèîíà;

- êîëè÷åñòâî âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ, äîïîëíèòåëüíî âíîñèìûõ â îáîãàùàåìûå èìè ïðîäóêòû, äîëæíî áûòü ðàññ÷èòàíî ñ ó÷åòîì èõ åñòåñòâåííîãî ñîäåðæàíèÿ â èñõîäíîì ïðîäóêòå èëè èñïîëüçóåìîì äëÿ åãî èçãîòîâëåíèÿ ñûðüå, à òàêæå ïîòåðü â ïðîöåññå ïðîèçâîäñòâà è õðàíåíèÿ, ñ òåì, ÷òîáû îáåñïå÷èòü ñîäåðæàíèå ýòèõ âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ íà óðîâíå íå íèæå ðåãëàìåíòèðóåìîãî â òå÷åíèå âñåãî ñðîêà ãîäíîñòè îáîãàùåííîãî ïðîäóêòà;

- âûáîð ñî÷åòàíèé, ôîðì, ñïîñîáîâ è ñòàäèé âíåñåíèÿ îáîãàùàþùèõ äîáàâîê äîëæåí ïðîâîäèòüñÿ ñ ó÷åòîì âîçìîæíîãî õèìè÷åñêîãî âçàèìîäåéñòâèÿ ìåæäó ñîáîé è ñ êîìïîíåíòàìè îáîãàùàåìîãî ïðîäóêòà è îáåñïå÷èâàòü ìàêñèìàëüíóþ ñîõðàííîñòü â ïðîöåññå ïðîèçâîäñòâà è õðàíåíèÿ;

- îáîãàùåíèå ïèùåâûõ ïðîäóêòîâ âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè íå äîëæíî óõóäøàòü ïîòðåáèòåëüñêèå ñâîéñòâà ýòèõ ïðîäóêòîâ: óìåíüøàòü ñîäåðæàíèå è óñâîÿåìîñòü äðóãèõ ñîäåðæàùèõñÿ â íèõ ïèùåâûõ âåùåñòâ, ñóùåñòâåííî èçìåíÿòü îðãàíîëåïòè÷åñêèå ñâîéñòâà ïðîäóêòîâ, ñîêðàùàòü èõ ñðîêè ãîäíîñòè;

- îáîãàùåíèå ïèùåâûõ ïðîäóêòîâ âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè íå äîëæíî âëèÿòü íà ïîêàçàòåëè áåçîïàñíîñòè;

- ãàðàíòèðîâàííîå ñîäåðæàíèå âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ â îáîãàùàåìûõ èìè ïðîäóêòàõ äîëæíî áûòü óêàçàíî íà èíäèâèäóàëüíîé óïàêîâêå ýòîãî ïðîäóêòà;

- ýôôåêòèâíîñòü âêëþ÷åíèÿ â íîâûå è ñïåöèàëèçèðîâàííûå ïèùåâûå ïðîäóêòû âèòàìèíîâ è/èëè ìèíåðàëüíûõ âåùåñòâ, ñ öåëüþ èõ îáîãàùåíèÿ, ñëåäóåò ïîäòâåðæäàòü ñïåöèàëüíûìè èññëåäîâàíèÿìè, äåìîíñòðèðóþùèìè èõ áåçîïàñíîñòü è ñïîñîáíîñòü óëó÷øàòü îáåñïå÷åííîñòü îðãàíèçìà âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè, ââåäåííûìè â ñîñòàâ îáîãàùåííûõ ïðîäóêòîâ, à òàêæå îêàçûâàòü ïîëîæèòåëüíîå âëèÿíèå íà ñîñòîÿíèå çäîðîâüÿ.

8.1.2. Äëÿ îáîãàùåíèÿ âèòàìèíàìè è/èëè ìèíåðàëüíûìè âåùåñòâàìè ðåêîìåíäîâàíû ñëåäóþùèå ãðóïïû ïèùåâûõ ïðîäóêòîâ:

- ìóêà è õëåáîáóëî÷íûå èçäåëèÿ,

- ìîëî÷íàÿ ïðîäóêöèÿ,

- íàïèòêè áåçàëêîãîëüíûå,

- ñîêîâàÿ ïðîäóêöèÿ èç ôðóêòîâ (âêëþ÷àÿ ÿãîäû) è îâîùåé (ñîêè, ôðóêòîâûå è (èëè) îâîùíûå íåêòàðû, ôðóêòîâûå è (èëè) îâîùíûå ñîêîñîäåðæàùèå íàïèòêè),

- ìàñëîæèðîâàÿ ïðîäóêöèÿ (ìàñëà ðàñòèòåëüíûå, ìàðãàðèíû, ñïðåäû, ìàéîíåçû, ñîóñû),

- ñîëü ïîâàðåííàÿ ïèùåâàÿ,

- çåðíîâûå ïðîäóêòû (ãîòîâûå çàâòðàêè, ãîòîâûå ê óïîòðåáëåíèþ ýêñòðóäèðîâàííûå ïðîäóêòû, ìàêàðîííûå è êðóïÿíûå èçäåëèÿ áûñòðîãî ïðèãîòîâëåíèÿ),

- ïèùåâûå êîíöåíòðàòû (êèñåëè, íàïèòêè áûñòðîãî ïðèãîòîâëåíèÿ, áëþäà, íå òðåáóþùèå âàðêè, êîíöåíòðàòû êàø áûñòðîãî ïðèãîòîâëåíèÿ),

- ïðîäóêòû áåëêîâûå èç ñåìÿí çåðíîâûõ, çåðíîáîáîâûõ è äðóãèõ êóëüòóð, à òàêæå ïèùåâûå ïðîäóêòû, ïðåäíàçíà÷åííûå äëÿ îòäåëüíûõ ãðóïï íàñåëåíèÿ:

- ïðîäóêòû äåòñêîãî ïèòàíèÿ,

- ïðîäóêòû äèåòè÷åñêîãî (ëå÷åáíîãî è ïðîôèëàêòè÷åñêîãî) ïèòàíèÿ,

- ôóíêöèîíàëüíûå ïèùåâûå ïðîäóêòû,

- ñïåöèàëèçèðîâàííûå ïèùåâûå ïðîäóêòû, â ò.÷. ñ çàäàííûì õèìè÷åñêèì ñîñòàâîì.

Âîçìîæíî îáîãàùåíèå âèòàìèíàìè è/èëè ìèíåðàëüíûìè âåùåñòâàìè êîíäèòåðñêèõ èçäåëèé (ñàõàðèñòûõ è ìó÷íûõ) è êîíöåíòðàòîâ ïëîäîâî-ÿãîäíûõ ñ ñàõàðîì.

8.1.3. Îáîãàùàòü âèòàìèíàìè è/èëè ìèíåðàëüíûìè âåùåñòâàìè ïðîäóêòû ìàññîâîãî ïîòðåáëåíèÿ ñëåäóåò â ñîîòâåòñòâèè ñ ïðèâåäåííûìè ðåêîìåíäàöèÿìè Ïðèëîæåíèÿ N 19 íàñòîÿùèõ ñàíèòàðíûõ ïðàâèë.

8.1.4. Íå ïîäëåæàò îáîãàùåíèþ âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè:

- ïèùåâûå ïðîäóêòû, íå ïîäâåðãàþùèåñÿ òåõíîëîãè÷åñêîé ïåðåðàáîòêå (ôðóêòû, îâîùè, ìÿñî, ìÿñî ïòèöû, ðûáà),

- íàïèòêè áðîæåíèÿ, à òàêæå íàïèòêè, ñîäåðæàùèå áîëåå 1,2% àëêîãîëÿ (çà èñêëþ÷åíèåì ñëàáîàëêîãîëüíûõ òîíèçèðóþùèõ íàïèòêîâ, â êîòîðûå âèòàìèíû è ìèíåðàëüíûå âåùåñòâà ââîäÿòñÿ ñ èíîé öåëüþ).

 

8.2. Ôîðìû è ïåðå÷åíü âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ,

èñïîëüçóåìûõ äëÿ îáîãàùåíèÿ ïèùåâûõ ïðîäóêòîâ

 

8.2.1. Ïðè ïðîèçâîäñòâå îáîãàùåííûõ âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè ïèùåâûõ ïðîäóêòîâ äîëæíû èñïîëüçîâàòüñÿ ôîðìû âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ â ñîîòâåòñòâèè ñ Ïðèëîæåíèåì N 18 è Ïðèëîæåíèåì N 19 íàñòîÿùèõ ñàíèòàðíûõ ïðàâèë. Äîïóñêàåòñÿ èñïîëüçîâàòü äëÿ îáîãàùåíèÿ ïèùåâûõ ïðîäóêòîâ âèòàìèí K2 (ìåíàõèíîí) è L-ìåòèëôîëàò êàëüöèÿ.

8.2.2. Íå äîïóñêàåòñÿ îáîãàùàòü ïèùåâûå ïðîäóêòû ìàññîâîãî ïîòðåáëåíèÿ íàòðèåì, õîëèíîì, èíîçèòîì, êàðíèòèíîì, òàóðèíîì, ìåäüþ, ìàðãàíöåì, ìîëèáäåíîì, õðîìîì è ñåëåíîì, çà èñêëþ÷åíèåì ñïåöèàëèçèðîâàííûõ ïèùåâûõ ïðîäóêòîâ (äëÿ ïèòàíèÿ ñïîðòñìåíîâ, äèåòè÷åñêîãî (ëå÷åáíîãî è ïðîôèëàêòè÷åñêîãî) ïèòàíèÿ, ñ çàäàííûì õèìè÷åñêèì ñîñòàâîì), ôóíêöèîíàëüíûõ ïèùåâûõ ïðîäóêòîâ è ïðîäóêòîâ äåòñêîãî ïèòàíèÿ, à òàêæå áèîëîãè÷åñêè àêòèâíûõ äîáàâîê ê ïèùå.

8.2.3. Ïðè âíåñåíèè â îáîãàùàåìûå ïðîäóêòû íàáîðà ìèêðîíóòðèåíòîâ ñëåäóåò èñïîëüçîâàòü ïèùåâûå îáîãàòèòåëè - âèòàìèííûå, ìèíåðàëüíûå èëè âèòàìèííî-ìèíåðàëüíûå ñìåñè (ïðåìèêñû) - ãîòîâûå ãîìîãåííûå ñìåñè ïèùåâûõ îáîãàòèòåëåé (âèòàìèíîâ è/èëè ìèíåðàëüíûõ âåùåñòâ), èçãîòîâëåííûå íà îñíîâå âåùåñòâà-íîñèòåëÿ, ÷òî ïîâûøàåò òî÷íîñòü âíåñåíèÿ è îáåñïå÷èâàåò áîëåå ðàâíîìåðíîå ðàñïðåäåëåíèå âèòàìèíîâ è/èëè ìèíåðàëüíûõ âåùåñòâ â îáîãàùàåìîì ïðîäóêòå. Èñïîëüçîâàíèå ïðåìèêñîâ ïîçâîëÿåò ïî ñîäåðæàíèþ íåñêîëüêèõ ìèêðîíóòðèåíòîâ êîíòðîëèðîâàòü êîëè÷åñòâî âíåñåííîãî ïðåìèêñà è, ñîîòâåòñòâåííî, ñîäåðæàíèå â ãîòîâîé ïðîäóêöèè îñòàëüíûõ âèòàìèíîâ è/èëè ìèíåðàëüíûõ âåùåñòâ, âíîñèìûõ â åãî ñîñòàâå.

 

8.3. Ðåãëàìåíòèðóåìûå óðîâíè ñîäåðæàíèÿ âèòàìèíîâ

è ìèíåðàëüíûõ âåùåñòâ â îáîãàùåííûõ ïðîäóêòàõ

 

8.3.1. Ïðîäóêò ñ÷èòàåòñÿ îáîãàùåííûì ïðè óñëîâèè, ÷òî åãî óñðåäíåííàÿ ñóòî÷íàÿ ïîðöèÿ ñîäåðæèò îò 15% äî 50% âèòàìèíîâ è/èëè ìèíåðàëüíûõ âåùåñòâ îò íîðìû ôèçèîëîãè÷åñêîé ïîòðåáíîñòè ÷åëîâåêà. Ìàññà (îáúåì) óñðåäíåííîé ñóòî÷íîé ïîðöèè óñòàíîâëåíà Ïðèëîæåíèåì N 20 íàñòîÿùèõ ñàíèòàðíûõ ïðàâèë.

Ïðè îáîãàùåíèè ïèùåâîãî ïðîäóêòà äîïîëíèòåëüíîå âíåñåíèå îáîãàùàþùåãî êîìïîíåíòà äîëæíî ñîñòàâëÿòü íå ìåíåå 10% îò íîðìû ôèçèîëîãè÷åñêîé ïîòðåáíîñòè ÷åëîâåêà.

Äëÿ îáîãàùåííûõ âûñîêîêàëîðèéíûõ ïèùåâûõ ïðîäóêòîâ (ñ ýíåðãåòè÷åñêîé öåííîñòüþ 350 êêàë è áîëåå íà 100 ã) ñîäåðæàíèå âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ äîëæíî ñîñòàâëÿòü îò 15% äî 50% îò íîðìû ôèçèîëîãè÷åñêîé ïîòðåáíîñòè îðãàíèçìà â ðàñ÷åòå íà 100 êêàë (1 ñòàíäàðòíóþ ïîðöèþ ïðîäóêòà).

8.3.2. Ïðè ïðîèçâîäñòâå îáîãàùåííûõ ïèùåâûõ ïðîäóêòîâ äîïóñêàåòñÿ óâåëè÷èâàòü ñîäåðæàíèå â íèõ âèòàìèíîâ ïî îòíîøåíèþ ê äåêëàðèðîâàííûì ïîêàçàòåëÿì, íî íå áîëåå ÷åì íà 70 ïðîöåíòîâ äëÿ âèòàìèíà C è íå áîëåå ÷åì íà 50 ïðîöåíòîâ äëÿ îñòàëüíûõ âèòàìèíîâ, â ñâÿçè ñ åñòåñòâåííûì ñíèæåíèåì êîëè÷åñòâà âèòàìèíîâ â îáîãàùåííûõ ïèùåâûõ ïðîäóêòàõ â ïðîöåññå èõ õðàíåíèÿ â òå÷åíèå ñðîêà ãîäíîñòè.

8.3.3. Ïðåäåëû äîïóñòèìûõ îòêëîíåíèé ôàêòè÷åñêîãî ñîäåðæàíèÿ âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ â îáîãàùåííûõ ïèùåâûõ ïðîäóêòàõ îò ãàðàíòèðîâàííîãî (íàíåñåííîãî íà ýòèêåòêó ïðè ìàðêèðîâêå) èëè çàëîæåííîãî ïî ðåöåïòóðå ñîñòàâëÿþò:

- äëÿ âèòàìèíîâ C, B1 B2, B6, ïàíòîòåíîâîé êèñëîòû, íèàöèíà è ìèíåðàëüíûõ âåùåñòâ ìàãíèÿ, êàëüöèÿ, ôîñôîðà, æåëåçà, öèíêà - +/- 20%;

- äëÿ âèòàìèíîâ A, D, E, B12, ôîëèåâîé êèñëîòû, áèîòèíà è ìèíåðàëüíîãî âåùåñòâà éîäà - +/- 30%;

- äëÿ ìèíåðàëüíîãî âåùåñòâà éîäà â ñîëè éîäèðîâàííîé - +/- 38%.

 

8.4. Ñïåöèàëüíûå òðåáîâàíèÿ ê îáîãàùåííûì âèòàìèíàìè

è ìèíåðàëüíûìè âåùåñòâàìè ïèùåâûì ïðîäóêòàì

 

8.4.1. Ðàçðàáîò÷èê îáîãàùåííûõ ïèùåâûõ ïðîäóêòîâ è (èëè) èõ èçãîòîâèòåëü îáÿçàíû äîïîëíèòåëüíî âêëþ÷èòü â íîðìàòèâíóþ è òåõíè÷åñêóþ äîêóìåíòàöèþ ãàðàíòèðîâàííîå ñîäåðæàíèå âèòàìèíîâ è/èëè ìèíåðàëüíûõ âåùåñòâ íà êîíåö ñðîêà ãîäíîñòè, à òàêæå òðåáîâàíèÿ ê èõ óïàêîâêå è ìàðêèðîâêå, ñðîêàì ãîäíîñòè è ìåòîäàì êîíòðîëÿ êà÷åñòâà è áåçîïàñíîñòè.

8.4.2. Êîíòðîëü ñîäåðæàíèÿ âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ â îáîãàùåííûõ ïèùåâûõ ïðîäóêòàõ, ïðè âíåñåíèè îáîãàùàþùèõ äîáàâîê â âèäå âèòàìèííûõ è/èëè âèòàìèííî-ìèíåðàëüíûõ ïðåìèêñîâ, äîïóñêàåòñÿ îñóùåñòâëÿòü ïî ñîäåðæàíèþ íåñêîëüêèõ êîìïîíåíòîâ, âõîäÿùèõ â ñîñòàâ îáîãàòèòåëåé, ïðè ýòîì îòâåòñòâåííîñòü ñîîòâåòñòâèÿ êîëè÷åñòâ âèòàìèíîâ è/èëè ìèíåðàëüíûõ âåùåñòâ ãàðàíòèðîâàííîìó â íîðìàòèâíîé äîêóìåíòàöèè íåñåò èçãîòîâèòåëü.

8.4.3. Ïðîèçâîäñòâî îáîãàùåííûõ ïèùåâûõ ïðîäóêòîâ îñóùåñòâëÿåòñÿ â ñîîòâåòñòâèè ñ íîðìàòèâíîé è òåõíè÷åñêîé äîêóìåíòàöèåé è äîëæíî îòâå÷àòü òåõíè÷åñêèì ðåãëàìåíòàì íà êàæäûé âèä ïðîäóêòà, à ïðè îòñóòñòâèè - ñàíèòàðíûì ïðàâèëàì è íîðìàì Ðîññèéñêîé Ôåäåðàöèè â îáëàñòè îáåñïå÷åíèÿ åå êà÷åñòâà è áåçîïàñíîñòè è ïîäòâåðæäàòüñÿ äåêëàðàöèåé î ñîîòâåòñòâèè.

8.4.4. Ââîçèìûå íà òåððèòîðèþ Ðîññèéñêîé Ôåäåðàöèè îáîãàùåííûå ïèùåâûå ïðîäóêòû äîëæíû îòâå÷àòü òðåáîâàíèÿì çàêîíîäàòåëüñòâà Ðîññèéñêîé Ôåäåðàöèè â îáëàñòè áåçîïàñíîñòè ïèùåâûõ ïðîäóêòîâ è òðåáîâàíèÿì íàñòîÿùèõ ñàíèòàðíûõ ïðàâèë.

8.4.5. Ðåãëàìåíòèðóåìîå ñîäåðæàíèå âèòàìèíîâ è ìèíåðàëüíûõ âåùåñòâ â îáîãàùàåìûõ èìè ïðîäóêòàõ äîëæíî êîíòðîëèðîâàòüñÿ ïðîèçâîäèòåëåì.

8.4.6. Ðàñôàñîâêà è óïàêîâêà îáîãàùåííûõ ïèùåâûõ ïðîäóêòîâ äîëæíû îáåñïå÷èâàòü ñîõðàíåíèå èõ êà÷åñòâà è áåçîïàñíîñòè íà âñåõ ýòàïàõ îáîðîòà ïðîäóêòîâ.

Èçãîòîâèòåëü îáîãàùåííûõ ïèùåâûõ ïðîäóêòîâ äîëæåí âûïóñêàòü èõ óïàêîâàííûìè è ìàðêèðîâàííûìè â ñîîòâåòñòâèè ñ çàêîíîäàòåëüñòâîì Ðîññèéñêîé Ôåäåðàöèè è òðåáîâàíèÿìè íàñòîÿùèõ ñàíèòàðíûõ ïðàâèë, íîðìàòèâíîé è òåõíè÷åñêîé äîêóìåíòàöèè.

 

8.5. Òðåáîâàíèÿ ê èíôîðìàöèè ïðè ìàðêèðîâêå ïèùåâûõ

ïðîäóêòîâ, îáîãàùåííûõ âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè

 

8.5.1. Îáîãàùåííûå âèòàìèíàìè è ìèíåðàëüíûìè âåùåñòâàìè ïèùåâûå ïðîäóêòû äîëæíû ñîïðîâîæäàòüñÿ èíôîðìàöèåé äëÿ ïîòðåáèòåëåé, ñîîòâåòñòâóþùåé òðåáîâàíèÿì çàêîíîäàòåëüñòâà Ðîññèéñêîé Ôåäåðàöèè.

8.5.2. Íà ïîòðåáèòåëüñêîé óïàêîâêå îáîãàùåííîé ïðîäóêöèè â íàèìåíîâàíèè òàêîé ïðîäóêöèè èëè â íåïîñðåäñòâåííîé áëèçîñòè îò íåãî äîëæíî áûòü óêàçàíî ñëîâî "îáîãàùåííûé". Äîïîëíèòåëüíî óêàçûâàþòñÿ íàèìåíîâàíèÿ âíåñåííûõ â ñîñòàâ òàêîé ïðîäóêöèè âèòàìèíîâ è/èëè ìèíåðàëüíûõ âåùåñòâ, èõ ãàðàíòèðîâàííîå ñîäåðæàíèå íà êîíåö ñðîêà ãîäíîñòè ïèùåâîãî ïðîäóêòà â ìã íà 100 ã (ìë) èëè ñðåäíþþ ñóòî÷íóþ ïîðöèþ ïðîäóêòà, à òàêæå ñîäåðæàíèå, âûðàæåííîå â ïðîöåíòàõ îò íîðì ôèçèîëîãè÷åñêîé ïîòðåáíîñòè â ýòèõ ïèùåâûõ âåùåñòâàõ, è ðåêîìåíäàöèè ïî ïðèìåíåíèþ èëè îñîáåííîñòè ïðèìåíåíèÿ òàêèõ ïèùåâûõ ïðîäóêòîâ, åñëè òàêîâûå óñòàíîâëåíû.

8.5.3. Èñïîëüçîâàíèå âèòàìèíîâ (C, E, áåòà-êàðîòèí) â êà÷åñòâå ïèùåâûõ äîáàâîê - àíòèîêèñëèòåëåé, âèòàìèíà B2, áåòà-êàðîòèíà è äðóãèõ êàðîòèíîèäîâ â êà÷åñòâå êðàñèòåëåé íå ÿâëÿåòñÿ îñíîâàíèåì äëÿ íàíåñåíèÿ íà ïîòðåáèòåëüñêóþ óïàêîâêó ïðîäóêöèè íàäïèñè: "Ñ âèòàìèíîì...".

8.5.4. Èíôîðìàöèÿ äëÿ ïîòðåáèòåëåé î ñîäåðæàíèè âèòàìèíîâ è/èëè ìèíåðàëüíûõ âåùåñòâ íàíîñèòñÿ íà êàæäóþ åäèíèöó ïîòðåáèòåëüñêîé óïàêîâêè îáîãàùåííûõ ïèùåâûõ ïðîäóêòîâ, íà êàæäóþ åäèíèöó ãðóïïîâîé óïàêîâêè, à òàêæå íà êàæäóþ åäèíèöó òðàíñïîðòíîé òàðû òàêîé ïðîäóêöèè.".

 

6.  Ïðèëîæåíèè N 1 "Ãèãèåíè÷åñêèå òðåáîâàíèÿ áåçîïàñíîñòè è ïèùåâîé öåííîñòè ïèùåâûõ ïðîäóêòîâ":

6.1. Ïóíêòû ñ èíäåêñàìè 1.1.1, 1.1.9, 1.1.15, 1.2.1, 1.7.4, 1.7.6, 1.7.7, 1.10.8 â ãðàôå 2 "Ïîêàçàòåëè" â ÷àñòè "Àíòèáèîòèêè" è èõ äîïóñòèìûå óðîâíè â ãðàôàõ 3 è 4 ïî ãðóïïàì ïðîäóêòîâ èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

 

┌──────────────┬───────────────┬──────────────────┬──────────────┐

│Èíäåêñ, ãðóïïà│  Ïîêàçàòåëè   │Äîïóñòèìûå óðîâíè,│  Ïðèìå÷àíèå 

  ïðîäóêòîâ                  │ ìã/êã, íå áîëåå               

├──────────────┼───────────────┼──────────────────┼──────────────┤

      1              2               3               4      

├──────────────┼───────────────┴──────────────────┴──────────────┤

│1.1.1.   Ìÿñî,│Àíòèáèîòèêè (êðîìå äèêèõ æèâîòíûõ) <*>:         

│â         ò.÷.├───────────────┬──────────────────┬──────────────┤

│ïîëóôàáðèêàòû,│ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

│ïàðíûå,       │(õëîðàìôåíèêîë)│                  │< 0,0003     

│îõëàæäåííûå,                                   │ââîäèòñÿ â   

│ïîäìîðîæåííûå,│                                 │äåéñòâèå ñ   

│çàìîðîæåííûå                                   │01.01.2012   

│(âñå      âèäû├───────────────┼──────────────────┼──────────────┤

│óáîéíûõ,      │òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

│ïðîìûñëîâûõ  è│ãðóïïà                                        

│äèêèõ         ├───────────────┼──────────────────┼──────────────┤

│æèâîòíûõ),   â│áàöèòðàöèí     │Íå äîïóñêàåòñÿ    │< 0,02       

│ò.÷.:                                                       

└──────────────┴───────────────┴──────────────────┴──────────────┘

 

┌──────────────┬─────────────────────────────────────────────────┐

│1.1.9.    Ìÿñî│Àíòèáèîòèêè (êðîìå äèêîé ïòèöû) <*>:            

│ïòèöû,  â  òîì├───────────────┬──────────────────┬──────────────┤

│÷èñëå         │ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

│ïîëóôàáðèêàòû,│(õëîðàìôåíèêîë)│                  │< 0,0003     

│îõëàæäåííûå,                                   │ââîäèòñÿ â   

│çàìîðîæåííûå                                   │äåéñòâèå ñ   

│(âñå      âèäû│                                 │01.01.2012   

│ïòèöû      äëÿ├───────────────┼──────────────────┼──────────────┤

│óáîÿ, ïåðíàòîé│òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

│äè÷è)         │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │áàöèòðàöèí     │Íå äîïóñêàåòñÿ    │< 0,02       

└──────────────┴───────────────┴──────────────────┴──────────────┘

 

┌──────────────┬─────────────────────────────────────────────────┐

│1.1.15. ßéöà è│Àíòèáèîòèêè <*>:                                 

│æèäêèå  ÿè÷íûå├───────────────┬──────────────────┬──────────────┤

│ïðîäóêòû      │ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

│(ìåëàíæ,      │(õëîðàìôåíèêîë)│                  │< 0,0003     

│áåëîê, æåëòîê)│                                 │ââîäèòñÿ â   

                                               │äåéñòâèå ñ   

                                               │01.01.2012   

              ├───────────────┼──────────────────┼──────────────┤

              │òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │áàöèòðàöèí     │Íå äîïóñêàåòñÿ    │< 0,02       

└──────────────┴───────────────┴──────────────────┴──────────────┘

 

┌──────────────┬─────────────────────────────────────────────────┐

│1.2.1. Ìîëîêî,│Àíòèáèîòèêè <*>:                                

│ñëèâêè ñûðûå è├───────────────┬──────────────────┬──────────────┤

│òåðìè÷åñêè    │ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

│îáðàáîòàííûå, │(õëîðàìôåíèêîë)│                  │< 0,0003     

│ïàõòà,                                         │ââîäèòñÿ     

│ñûâîðîòêà                                      │â äåéñòâèå ñ 

│ìîëî÷íàÿ,                                      │01.01.2012   

│æèäêèå        ├───────────────┼──────────────────┼──────────────┤

│êèñëîìîëî÷íûå │òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

│ïðîäóêòû,    â│ãðóïïà                                        

│ò.÷.   éîãóðò,├───────────────┼──────────────────┼──────────────┤

│ñìåòàíà,      │ïåíèöèëëèíû    │Íå äîïóñêàåòñÿ    │< 0,004      

│íàïèòêè     íà├───────────────┼──────────────────┼──────────────┤

│ìîëî÷íîé      │ñòðåïòîìèöèí   │Íå äîïóñêàåòñÿ    │< 0,2        

│îñíîâå                                                      

└──────────────┴───────────────┴──────────────────┴──────────────┘

 

┌──────────────┬─────────────────────────────────────────────────┐

│1.7.4.    Æèð-│Àíòèáèîòèêè <*>:                                

│ñûðåö ãîâÿæèé,├───────────────┬──────────────────┬──────────────┤

│ñâèíîé,       │ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

│áàðàíèé è  äð.│(õëîðàìôåíèêîë)│                  │< 0,0003     

│óáîéíûõ                                        │ââîäèòñÿ     

│æèâîòíûõ                                       │â äåéñòâèå ñ 

│(îõëàæäåííûé, │                                 │01.01.2012   

│çàìîðîæåííûé).├───────────────┼──────────────────┼──────────────┤

│Øïèê    ñâèíîé│òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

│îõëàæäåííûé,  │ãðóïïà                                        

│çàìîðîæåííûé, ├───────────────┼──────────────────┼──────────────┤

│ñîëåíûé,      │áàöèòðàöèí     │Íå äîïóñêàåòñÿ    │< 0,02       

│êîï÷åíûé     è│                                              

│ïðîäóêòû    èç│                                              

│íåãî                                                        

├──────────────┼───────────────┴──────────────────┴──────────────┤

│1.7.6. Ìàñëî  │Àíòèáèîòèêè <*>:                                

│êîðîâüå       ├───────────────┬──────────────────┬──────────────┤

              │ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

              │(õëîðàìôåíèêîë)│                  │< 0,0003     

                                               │ââîäèòñÿ â   

                                               │äåéñòâèå ñ   

                                               │01.01.2012   

              ├───────────────┼──────────────────┼──────────────┤

              │òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │ïåíèöèëëèíû    │Íå äîïóñêàåòñÿ    │< 0,004      

              ├───────────────┼──────────────────┼──────────────┤

              │ñòðåïòîìèöèí   │Íå äîïóñêàåòñÿ    │< 0,2        

├──────────────┼───────────────┴──────────────────┴──────────────┤

│1.7.7. Æèðîâûå│Àíòèáèîòèêè <*>:                                

│ïðîäóêòû    íà├───────────────┬──────────────────┬──────────────┤

│îñíîâå        │ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

│ñî÷åòàíèÿ     │(õëîðàìôåíèêîë)│                  │< 0,0003     

│æèâîòíûõ,                                      │ââîäèòñÿ     

│âêëþ÷àÿ                                        │â äåéñòâèå ñ 

│ìîëî÷íûé  æèð,│                                 │01.01.2012   

│è ðàñòèòåëüíûõ├───────────────┼──────────────────┼──────────────┤

│æèðîâ         │òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │áàöèòðàöèí     │Íå äîïóñêàåòñÿ    │< 0,02       

└──────────────┴───────────────┴──────────────────┴──────────────┘

 

┌──────────────┬─────────────────────────────────────────────────┐

│1.10.8. ÁÀÄ íà│Àíòèáèîòèêè <*>:                                

│îñíîâå                                                        

│ïåðåðàáîòêè                                                   

│ìÿñî-ìîëî÷íîãî│                                                

│ñûðüÿ, â  ò.÷.│                                                 

│ñóáïðîäóêòîâ, │                                                

│ïòèöû;                                                        

│÷ëåíèñòîíîãèõ,│                                                

│çåìíîâîäíûõ,                                                   

│ïðîäóêòîâ                                                     

│ï÷åëîâîäñòâà                                                  

│(ìàòî÷íîå                                                     

│ìîëî÷êî,                                                       

│ïðîïîëèñ     è│                                                

│äð.) - ñóõèå                                                  

├──────────────┼───────────────┬──────────────────┬──────────────┤

│-    ÁÀÄ    íà│ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

│îñíîâå ìÿñíîãî│(õëîðàìôåíèêîë)│                  │< 0,0003     

│ñûðüÿ, â  ò.÷.│                                 │ââîäèòñÿ     

│ñóáïðîäóêòîâ                                   │â äåéñòâèå ñ 

│ïòèöû                                          │01.01.2012   

              ├───────────────┼──────────────────┼──────────────┤

              │òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │áàöèòðàöèí     │Íå äîïóñêàåòñÿ    │< 0,02       

├──────────────┼───────────────┼──────────────────┼──────────────┤

│-    ÁÀÄ    íà│ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01        

│îñíîâå        │(õëîðàìôåíèêîë)│                  │< 0,0003     

│ìîëî÷íîãî                                      │ââîäèòñÿ â   

│ñûðüÿ                                          │äåéñòâèå ñ   

                                               │01.01.2012   

              ├───────────────┼──────────────────┼──────────────┤

              │òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │ñòðåïòîìèöèí   │Íå äîïóñêàåòñÿ    │< 0,2        

              ├───────────────┼──────────────────┼──────────────┤

              │ïåíèöèëëèíû    │Íå äîïóñêàåòñÿ    │< 0,004      

└──────────────┴───────────────┴──────────────────┴──────────────┘

 

6.2.  ïðèìå÷àíèè ïîä òàáëèöåé ê ïóíêòó 1.1 ôðàçó "<*> Ïðè èñïîëüçîâàíèè õèìè÷åñêèõ ìåòîäîâ îïðåäåëåíèÿ ãðèçèíà, áàöèòðàöèíà è àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû ïåðåñ÷åò èõ ôàêòè÷åñêîãî ñîäåðæàíèÿ â åä./ã ïðîèçâîäèòñÿ ïî àêòèâíîñòè ñòàíäàðòà." çàìåíèòü íà "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. 3.15)".

6.3.  ïðèìå÷àíèè ïîä òàáëèöåé ê ïóíêòó 1.2 ôðàçó "<*> Ïðè èñïîëüçîâàíèè õèìè÷åñêèõ ìåòîäîâ îïðåäåëåíèÿ ñòðåïòîìèöèíà, ïåíèöèëëèíà è àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû ïåðåñ÷åò èõ ôàêòè÷åñêîãî ñîäåðæàíèÿ â åä./ã ïðîèçâîäèòñÿ ïî àêòèâíîñòè ñòàíäàðòà." çàìåíèòü íà "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. 3.15)".

6.4.  ïðèìå÷àíèè ïîä òàáëèöåé ê ïóíêòó 1.7 ôðàçó "<**> Ïðè èñïîëüçîâàíèè õèìè÷åñêèõ ìåòîäîâ îïðåäåëåíèÿ áàöèòðàöèíà è àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû ïåðåñ÷åò èõ ôàêòè÷åñêîãî ñîäåðæàíèÿ â åä./ã ïðîèçâîäèòñÿ ïî àêòèâíîñòè ñòàíäàðòà." çàìåíèòü íà "<**> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. 3.15)".

6.5. Ïðèìå÷àíèå ïîä òàáëèöåé ê ïóíêòó 1.10 èçëîæèòü â ñëåäóþùåé ðåäàêöèè: "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ ïåñòèöèäîâ è àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. ï. 3.12, 3.13, 3.15)".

6.6. Ïóíêòû ñ èíäåêñàìè 1.3.1, 1.3.4, 1.3.5, 1.3.7, 1.5.6, 1.9.2, 1.9.3 ïî ãðàôå "Ïîêàçàòåëè" äîïîëíèòü ïîçèöèåé "Àíòèáèîòèêè <*>:" è èõ äîïóñòèìûå óðîâíè â ãðàôàõ 3 è 4 ïî ãðóïïàì ïðîäóêòîâ èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

 

Èíäåêñ, ãðóïïà
ïðîäóêòîâ  

Ïîêàçàòåëè  

Äîïóñòèìûå óðîâíè,
ìã/êã, íå áîëåå 

Ïðèìå÷àíèå 

1      

2      

3        

4      

1.3.1.    Ðûáà
æèâàÿ,   ðûáà-
ñûðåö,       
îõëàæäåííàÿ, 
ìîðîæåíàÿ,   
ôàðø,    ôèëå,
ìÿñî   ìîðñêèõ
ìëåêîïèòàþùèõ

Àíòèáèîòèêè (â ðûáå ïðóäîâîé è ñàäêîâîãî        
ñîäåðæàíèÿ) <*>:                                

òåòðàöèêëèíîâàÿ
ãðóïïà        

Íå äîïóñêàåòñÿ   

< 0,01       

 

1.3.4. Èêðà  è
ìîëîêè  ðûá  è
ïðîäóêòû    èç
íèõ;   àíàëîãè
èêðû         

Àíòèáèîòèêè (äëÿ ðûá ïðóäîâûõ è ñàäêîâîãî       
ñîäåðæàíèÿ) <*>:                                

òåòðàöèêëèíîâàÿ
ãðóïïà        

Íå äîïóñêàåòñÿ   

< 0,01       

 

1.3.5.  Ïå÷åíü
ðûá è ïðîäóêòû
èç íåå       

Àíòèáèîòèêè (äëÿ ðûá ïðóäîâûõ è ñàäêîâîãî       
ñîäåðæàíèÿ) <*>:                                 

òåòðàöèêëèíîâàÿ
ãðóïïà        

Íå äîïóñêàåòñÿ   

< 0,01       

 

1.3.7.       
Íåðûáíûå     
îáúåêòû      
ïðîìûñëà     
(ìîëëþñêè,   
ðàêîîáðàçíûå,
áåñïîçâîíî÷- 
íûå, âîäîðîñëè
ìîðñêèå)     è
ïðîäóêòû    èõ
ïåðåðàáîòêè,  
çåìíîâîäíûå, 
ïðåñìûêàþùèåñÿ

Àíòèáèîòèêè (äëÿ îáúåêòîâ ïðîìûñëà ïðóäîâûõ è   
ñàäêîâîãî ñîäåðæàíèÿ) <*>:                      

òåòðàöèêëèíîâàÿ
ãðóïïà        

Íå äîïóñêàåòñÿ   

< 0,01       

 

1.5.6. Ìåä   

Àíòèáèîòèêè <*> (â èìïîðòèðóåìîé ïðîäóêöèè ïî   
èíôîðìàöèè ïîñòàâùèêà):                         

òåòðàöèêëèíîâàÿ
ãðóïïà        

Íå äîïóñêàåòñÿ   

< 0,01       

 

┌──────────────┬───────────────┬──────────────────┬──────────────┐

│1.9.2.        │Àíòèáèîòèêè                                    

│Êîíöåíòðàòû   │<*>:                                          

│ìîëî÷íûõ      ├───────────────┼──────────────────┼──────────────┤

│ñûâîðîòî÷íûõ  │ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

│áåëêîâ,       │(õëîðàìôåíèêîë)│                  │< 0,0003     

│êàçåèí,                                        │ââîäèòñÿ â   

│êàçåèíàòû,                                     │äåéñòâèå ñ   

│ãèäðîëèçàòû                                    │01.01.2012   

│ìîëî÷íûõ      ├───────────────┼──────────────────┼──────────────┤

│áåëêîâ        │òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │ïåíèöèëëèíû    │Íå äîïóñêàåòñÿ    │< 0,004      

              ├───────────────┼──────────────────┼──────────────┤

              │ñòðåïòîìèöèí   │Íå äîïóñêàåòñÿ    │< 0,2        

└──────────────┴───────────────┴──────────────────┴──────────────┘

 

┌──────────────┬───────────────┬──────────────────┬──────────────┐

│1.9.3.        │Àíòèáèîòèêè                                   

│Êîíöåíòðàòû   │<*>:                                          

│áåëêîâ   êðîâè├───────────────┼──────────────────┼──────────────┤

│(ñóõîé        │ëåâîìèöåòèí    │Íå äîïóñêàåòñÿ    │< 0,01       

│êîíöåíòðàò    │(õëîðàìôåíèêîë)│                  │< 0,0003     

│ïëàçìû,                                        │ââîäèòñÿ â   

│ñûâîðîòêè,                                     │äåéñòâèå ñ   

│àëüáóìèí                                       │01.01.2012   

│ïèùåâîé)      ├───────────────┼──────────────────┼──────────────┤

              │òåòðàöèêëèíîâàÿ│Íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │áàöèòðàöèí     │Íå äîïóñêàåòñÿ    │< 0,02       

└──────────────┴───────────────┴──────────────────┴──────────────┘

 

6.7. Ïðèìå÷àíèÿ ïîä òàáëèöàìè ê ïóíêòàì 1.3, 1.5, 1.9 äîïîëíèòü ñëîâîì "àíòèáèîòèêîâ" è èçëîæèòü â ñëåäóþùåé ðåäàêöèè: "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ ïåñòèöèäîâ è àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. ï. 3.12, 3.13, 3.15)".

7.  Ïðèëîæåíèè 3 "Ãèãèåíè÷åñêèå òðåáîâàíèÿ áåçîïàñíîñòè è ïèùåâîé öåííîñòè ïðîäóêòîâ äåòñêîãî ïèòàíèÿ":

7.1. Â ðàçäåëå 3.1 "Ïðîäóêòû äëÿ ïèòàíèÿ äåòåé ðàííåãî âîçðàñòà" â ïóíêòàõ 3.1.1.1, 3.1.2.3, 3.1.4.1, 3.1.4.3, â ïîäðàçäåëå "2) Ïîêàçàòåëè áåçîïàñíîñòè" ïîêàçàòåëü "Àíòèáèîòèêè" è äîïóñòèìûå óðîâíè â ãðàôàõ 2 è 3 èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

 

3.1.1.1. Àäàïòèðîâàííûå ìîëî÷íûå ñìåñè (ñóõèå, æèäêèå, ïðåñíûå è êèñëîìîëî÷íûå)

 

┌────────────────────────────┬──────────────────┬────────────────┐

        Ïîêàçàòåëè          │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                              ìã/êã, íå áîëåå │               

├────────────────────────────┼──────────────────┼────────────────┤

             1                       2                3      

├────────────────────────────┴──────────────────┴────────────────┤

│Àíòèáèîòèêè <*>:                                               

├────────────────────────────┬──────────────────┬────────────────┤

│ ëåâîìèöåòèí (õëîðàìôåíèêîë)│íå äîïóñêàåòñÿ    │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│ òåòðàöèêëèíîâàÿ ãðóïïà     │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│ ïåíèöèëëèíû                │íå äîïóñêàåòñÿ    │< 0,004        

├────────────────────────────┼──────────────────┼────────────────┤

│ ñòðåïòîìèöèí               │íå äîïóñêàåòñÿ    │< 0,2          

└────────────────────────────┴──────────────────┴────────────────┘

 

"3.1.2.3. Êàøè ñóõèå ìîëî÷íûå, òðåáóþùèå âàðêè"

 

┌─────────────────────────────────┬────────────┬─────────────────┐

           Ïîêàçàòåëè            │ Äîïóñòèìûå │   Ïðèìå÷àíèÿ   

                                 │ óðîâíè, ìã/│                

                                 │êã, íå áîëåå│                

├─────────────────────────────────┴────────────┴─────────────────┤

│Àíòèáèîòèêè <*>:                                               

├─────────────────────────────────┬────────────┬─────────────────┤

│ ëåâîìèöåòèí (õëîðàìôåíèêîë)     │íå äîïóñêà- │< 0,01          

                                 │åòñÿ        │< 0,0003 ââîäèòñÿ│

                                             │â äåéñòâèå ñ    

                                             │01.01.2012      

├─────────────────────────────────┼────────────┼─────────────────┤

│ òåòðàöèêëèíîâàÿ ãðóïïà          │íå äîïóñêà- │< 0,01          

                                 │åòñÿ                        

├─────────────────────────────────┼────────────┼─────────────────┤

│ ïåíèöèëëèíû                     │íå äîïóñêà- │< 0,004         

                                 │åòñÿ                        

├─────────────────────────────────┼────────────┼─────────────────┤

│ ñòðåïòîìèöèí                    │íå äîïóñêà- │< 0,2           

                                 │åòñÿ                        

└─────────────────────────────────┴────────────┴─────────────────┘

 

3.1.4.1. Êîíñåðâû èç ìÿñà (ãîâÿäèíû, ñâèíèíû, áàðàíèíû, ïòèöû è äð.), â ò.÷. ñ äîáàâëåíèåì ñóáïðîäóêòîâ

 

┌────────────────────────────┬──────────────────┬────────────────┐

         Ïîêàçàòåëè         │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                            │ ìã/êã, íå áîëåå                 

├────────────────────────────┴──────────────────┴────────────────┤

│Àíòèáèîòèêè <*>:                                               

├────────────────────────────┬──────────────────┬────────────────┤

│ ëåâîìèöåòèí (õëîðàìôåíèêîë)│íå äîïóñêàåòñÿ    │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│ òåòðàöèêëèíîâàÿ ãðóïïà     │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│ áàöèòðàöèí                 │íå äîïóñêàåòñÿ    │< 0,02          

└────────────────────────────┴──────────────────┴────────────────┘

 

3.1.4.3. Ìÿñî-ðàñòèòåëüíûå êîíñåðâû

 

┌────────────────────────────┬──────────────────┬────────────────┐

         Ïîêàçàòåëè         │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                            │ ìã/êã, íå áîëåå                 

├────────────────────────────┴──────────────────┴────────────────┤

│Àíòèáèîòèêè <*>:                                               

├────────────────────────────┬──────────────────┬────────────────┤

│ ëåâîìèöåòèí (õëîðàìôåíèêîë)│íå äîïóñêàåòñÿ    │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│ òåòðàöèêëèíîâàÿ ãðóïïà     │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│ áàöèòðàöèí                 │íå äîïóñêàåòñÿ    │< 0,02         

└────────────────────────────┴──────────────────┴────────────────┘

 

7.2. Â ðàçäåëå 3.1 "Ïðîäóêòû äëÿ ïèòàíèÿ äåòåé ðàííåãî âîçðàñòà" â ïóíêòå 3.1.5.2 "Ðûáî-ðàñòèòåëüíûå êîíñåðâû" ïîäðàçäåë "2) Ïîêàçàòåëè áåçîïàñíîñòè" äîïîëíèòü ïîçèöèåé "Àíòèáèîòèêè <*>:" è èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

 

Àíòèáèîòèêè <*> (äëÿ ðûáû ïðóäîâîé è ñàäêîâîãî ñîäåðæàíèÿ):    

òåòðàöèêëèíîâàÿ ãðóïïà    

íå äîïóñêàåòñÿ   

< 0,01          

 

7.3.  ïðèìå÷àíèè ïîä òàáëèöåé ê ðàçäåëó 3.1 ôðàçó "<*> Ïðè èñïîëüçîâàíèè õèìè÷åñêèõ ìåòîäîâ îïðåäåëåíèÿ ãðèçèíà, áàöèòðàöèíà, àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû, ïåíèöèëëèíà, ñòðåïòîìèöèíà ïåðåñ÷åò èõ ôàêòè÷åñêîãî ñîäåðæàíèÿ â åä./ã ïðîèçâîäèòñÿ ïî àêòèâíîñòè ñòàíäàðòà." çàìåíèòü íà "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. 3.15)".

7.4. Â ðàçäåëå 3.2 "Ïðîäóêòû äëÿ ïèòàíèÿ äîøêîëüíèêîâ è øêîëüíèêîâ" â ïóíêòàõ 3.2.1.1, 3.2.3.1, 3.2.3.2, 3.2.4.1, 3.2.4.3 â ïîäðàçäåëå "2) Ïîêàçàòåëè áåçîïàñíîñòè" ïîçèöèþ "Àíòèáèîòèêè" è äîïóñòèìûå óðîâíè ïî ãðóïïàì ïðîäóêòîâ èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

 

3.2.1.1. Êîíñåðâû ìÿñíûå (â ò.÷. èç ìÿñà ïòèöû)

 

┌────────────────────────────┬──────────────────┬────────────────┐

        Ïîêàçàòåëè          │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                            │ ìã/êã, íå áîëåå                 

├────────────────────────────┼──────────────────┼────────────────┤

│ Àíòèáèîòèêè <*>:                                            

├────────────────────────────┼──────────────────┼────────────────┤

│ ëåâîìèöåòèí (õëîðàìôåíèêîë)│íå äîïóñêàåòñÿ    │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│ òåòðàöèêëèíîâàÿ ãðóïïà     │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│ áàöèòðàöèí                 │íå äîïóñêàåòñÿ    │< 0,02         

└────────────────────────────┴──────────────────┴────────────────┘

 

3.2.3.1. Ïîëóôàáðèêàòû èç ðûáû è íåðûáíûõ îáúåêòîâ ïðîìûñëà

 

Àíòèáèîòèêè <*>: äëÿ ðûáû ïðóäîâîé è ñàäêîâîãî ñîäåðæàíèÿ      

òåòðàöèêëèíîâàÿ ãðóïïà    

íå äîïóñêàåòñÿ   

< 0,01         

 

3.2.3.2. Êóëèíàðíûå èçäåëèÿ èç ðûáû è íåðûáíûõ îáúåêòîâ ïðîìûñëà

 

┌────────────────────────────────────────────────────────────────┐

│Àíòèáèîòèêè <*>:                                               

├────────────────────────────┬──────────────────┬────────────────┤

│Ëåâîìèöåòèí (õëîðàìôåíèêîë) │  íå äîïóñêàåòñÿ  │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012 (äëÿ │

                                              │ïðîäóêòîâ ñ    

                                              │ìîëî÷íûì       

                                              │êîìïîíåíòîì)   

├────────────────────────────┼──────────────────┼────────────────┤

│òåòðàöèêëèíîâîé ãðóïïû        íå äîïóñêàåòñÿ  │< 0,01 (äëÿ    

                                              │ðûáû ïðóäîâîé è │

                                              │ñàäêîâîãî      

                                              │ñîäåðæàíèÿ;    

                                              │äëÿ ïðîäóêòîâ ñ │

                                              │ìîëî÷íûì, ÿè÷íûì│

                                              │êîìïîíåíòîì)   

├────────────────────────────┼──────────────────┼────────────────┤

│ïåíèöèëëèíû                 │ íå äîïóñêàåòñÿ   │< 0,004 (äëÿ   

                                              │ïðîäóêòîâ ñ    

                                              │ìîëî÷íûì       

                                              │êîìïîíåíòîì)   

├────────────────────────────┼──────────────────┼────────────────┤

│ñòðåïòîìèöèí                │ íå äîïóñêàåòñÿ   │< 0,2 (äëÿ     

                                              │ïðîäóêòîâ ñ    

                                              │ìîëî÷íûì       

                                              │êîìïîíåíòîì)   

├────────────────────────────┼──────────────────┼────────────────┤

│áàöèòðàöèí                  │ íå äîïóñêàåòñÿ   │< 0,02 (äëÿ    

                                              │ïðîäóêòîâ ñ    

                                              │ÿè÷íûì         

                                              │êîìïîíåíòîì)   

└────────────────────────────┴──────────────────┴────────────────┘

 

3.2.4.1. Ìîëîêî; ñëèâêè; êèñëîìîëî÷íûå ïðîäóêòû, â ò.÷. éîãóðòû; íàïèòêè íà ìîëî÷íîé îñíîâå

 

┌────────────────────────────┬──────────────────┬────────────────┐

         Ïîêàçàòåëè         │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                            │ ìã/êã, íå áîëåå                 

├────────────────────────────┼──────────────────┼────────────────┤

│ Àíòèáèîòèêè <*>:                                            

├────────────────────────────┼──────────────────┼────────────────┤

│ëåâîìèöåòèí (õëîðàìôåíèêîë) │íå äîïóñêàåòñÿ    │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│òåòðàöèêëèíîâàÿ ãðóïïà      │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│Ïåíèöèëëèíû                 │íå äîïóñêàåòñÿ    │< 0,004        

├────────────────────────────┼──────────────────┼────────────────┤

│Ñòðåïòîìèöèí                │íå äîïóñêàåòñÿ    │< 0,2          

└────────────────────────────┴──────────────────┴────────────────┘

 

3.2.4.3. Ñûðû (òâåðäûå, ïîëóòâåðäûå, ìÿãêèå, ðàññîëüíûå, ïëàâëåíûå)

 

┌────────────────────────────┬──────────────────┬────────────────┐

         Ïîêàçàòåëè         │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                            │ ìã/êã, íå áîëåå                 

├────────────────────────────┼──────────────────┼────────────────┤

│ Àíòèáèîòèêè <*>:                                            

├────────────────────────────┼──────────────────┼────────────────┤

│ëåâîìèöåòèí (õëîðàìôåíèêîë) │íå äîïóñêàåòñÿ    │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â      

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│òåòðàöèêëèíîâàÿ ãðóïïà      │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│Ïåíèöèëëèíû                 │íå äîïóñêàåòñÿ    │< 0,004        

├────────────────────────────┼──────────────────┼────────────────┤

│Ñòðåïòîìèöèí                │íå äîïóñêàåòñÿ    │< 0,2          

└────────────────────────────┴──────────────────┴────────────────┘

 

7.5.  ïðèìå÷àíèè ïîä òàáëèöåé ê ïóíêòó 3.2.3.2 "Êóëèíàðíûå èçäåëèÿ èç ðûáû è íåðûáíûõ îáúåêòîâ ïðîìûñëà" ôðàçó "<*> Ïðè èñïîëüçîâàíèè õèìè÷åñêèõ ìåòîäîâ îïðåäåëåíèÿ ãðèçèíà, áàöèòðàöèíà, àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû, ïåíèöèëëèíà, ñòðåïòîìèöèíà ïåðåñ÷åò èõ ôàêòè÷åñêîãî ñîäåðæàíèÿ â åä./ã ïðîèçâîäèòñÿ ïî àêòèâíîñòè ñòàíäàðòà." çàìåíèòü íà "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. 3.15)".

7.6.  ïðèìå÷àíèè ïîä òàáëèöåé ê ïóíêòó 3.2.4 "Ìîëîêî è ìîëî÷íûå ïðîäóêòû." ôðàçó "<*> Ïðè èñïîëüçîâàíèè õèìè÷åñêèõ ìåòîäîâ îïðåäåëåíèÿ ãðèçèíà, áàöèòðàöèíà, àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû, ïåíèöèëëèíà, ñòðåïòîìèöèíà ïåðåñ÷åò èõ ôàêòè÷åñêîãî ñîäåðæàíèÿ â åä./ã ïðîèçâîäèòñÿ ïî àêòèâíîñòè ñòàíäàðòà." çàìåíèòü íà "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. 3.15)".

7.7.  ðàçäåëå 3.3 "Ñïåöèàëèçèðîâàííûå ïðîäóêòû äëÿ ëå÷åáíîãî ïèòàíèÿ äåòåé" â ïóíêòàõ 3.3.1, 3.3.3, 3.3.6.2, 3.3.7, â ïîäðàçäåëå "2) Ïîêàçàòåëè áåçîïàñíîñòè" ïîçèöèþ "Àíòèáèîòèêè" è äîïóñòèìûå óðîâíè ïî ãðóïïàì ïðîäóêòîâ èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

3.3.1. Íèçêîëàêòîçíûå è áåçëàêòîçíûå ïðîäóêòû

 

┌────────────────────────────┬──────────────────┬────────────────┐

         Ïîêàçàòåëè         │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                              ìã/êã, íå áîëåå │               

├────────────────────────────┼──────────────────┼────────────────┤

│ Àíòèáèîòèêè <*>:                                            

├────────────────────────────┼──────────────────┼────────────────┤

│ëåâîìèöåòèí (õëîðàìôåíèêîë) │íå äîïóñêàåòñÿ    │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå       

                                              │ñ 01.01.2012   

├────────────────────────────┼──────────────────┼────────────────┤

│òåòðàöèêëèíîâàÿ ãðóïïà      │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│Ïåíèöèëëèíû                 │íå äîïóñêàåòñÿ    │< 0,004        

├────────────────────────────┼──────────────────┼────────────────┤

│Ñòðåïòîìèöèí                │íå äîïóñêàåòñÿ    │< 0,2          

└────────────────────────────┴──────────────────┴────────────────┘

 

3.3.3. Ñóõèå ìîëî÷íûå âûñîêîáåëêîâûå ïðîäóêòû

 

┌────────────────────────────┬──────────────────┬────────────────┐

         Ïîêàçàòåëè         │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                              ìã/êã, íå áîëåå │                

├────────────────────────────┼──────────────────┼────────────────┤

│ Àíòèáèîòèêè <*>:                                            

├────────────────────────────┼──────────────────┼────────────────┤

│ëåâîìèöåòèí (õëîðàìôåíèêîë) │íå äîïóñêàåòñÿ    │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│òåòðàöèêëèíîâàÿ ãðóïïà      │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│Ïåíèöèëëèíû                 │íå äîïóñêàåòñÿ    │< 0,004        

├────────────────────────────┼──────────────────┼────────────────┤

│Ñòðåïòîìèöèí                │íå äîïóñêàåòñÿ    │< 0,2          

└────────────────────────────┴──────────────────┴────────────────┘

 

3.3.6.2. Ñóáëèìèðîâàííûå ïðîäóêòû íà ìÿñíîé îñíîâå

 

┌────────────────────────────┬──────────────────┬────────────────┐

         Ïîêàçàòåëè         │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                              ìã/êã, íå áîëåå │               

├────────────────────────────┼──────────────────┼────────────────┤

│ Àíòèáèîòèêè <*>:                                            

├────────────────────────────┼──────────────────┼────────────────┤

│ ëåâîìèöåòèí (õëîðàìôåíèêîë)│íå äîïóñêàåòñÿ    │< 0,01          

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│ òåòðàöèêëèíîâàÿ ãðóïïà     │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│ áàöèòðàöèí                 │íå äîïóñêàåòñÿ    │< 0,02         

└────────────────────────────┴──────────────────┴────────────────┘

 

3.3.7. Ïðîäóêòû äëÿ íåäîíîøåííûõ äåòåé

 

┌────────────────────────────┬──────────────────┬────────────────┐

         Ïîêàçàòåëè         │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                              ìã/êã, íå áîëåå │               

├────────────────────────────┼──────────────────┼────────────────┤

│ Àíòèáèîòèêè <*>:                                            

├────────────────────────────┼──────────────────┼────────────────┤

│ëåâîìèöåòèí (õëîðàìôåíèêîë) │íå äîïóñêàåòñÿ    │0,01           

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│òåòðàöèêëèíîâàÿ ãðóïïà      │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│Ïåíèöèëëèíû                 │íå äîïóñêàåòñÿ    │< 0,004        

├────────────────────────────┼──────────────────┼────────────────┤

│Ñòðåïòîìèöèí                │íå äîïóñêàåòñÿ    │< 0,2          

└────────────────────────────┴──────────────────┴────────────────┘

 

7.8.  ïðèìå÷àíèè ïîä òàáëèöåé ê ðàçäåëó 3.3 "Ñïåöèàëèçèðîâàííûå ïðîäóêòû äëÿ ëå÷åáíîãî ïèòàíèÿ äåòåé" ôðàçó "<*> Ïðè èñïîëüçîâàíèè õèìè÷åñêèõ ìåòîäîâ îïðåäåëåíèÿ ãðèçèíà, áàöèòðàöèíà, àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû, ïåíèöèëëèíà, ñòðåïòîìèöèíà ïåðåñ÷åò èõ ôàêòè÷åñêîãî ñîäåðæàíèÿ â åä./ã ïðîèçâîäèòñÿ ïî àêòèâíîñòè ñòàíäàðòà." çàìåíèòü íà "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. 3.15)".

7.9. Â ðàçäåëå 3.5 "Ïðîäóêòû äëÿ ïèòàíèÿ áåðåìåííûõ è êîðìÿùèõ æåíùèí" â ïóíêòå 3.5.1 â ïîäðàçäåëå "2) Ïîêàçàòåëè áåçîïàñíîñòè" ïîçèöèþ "Àíòèáèîòèêè" è äîïóñòèìûå óðîâíè ïî ãðóïïàì ïðîäóêòîâ èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

 

3.5.1. "Ïðîäóêòû íà ìîëî÷íîé îñíîâå è íà îñíîâå èçîëÿòà ñîåâîãî áåëêà

 

┌────────────────────────────┬──────────────────┬────────────────┐

         Ïîêàçàòåëè         │Äîïóñòèìûå óðîâíè,│   Ïðèìå÷àíèÿ  

                            │ ìã/êã, íå áîëåå                 

├────────────────────────────┼──────────────────┼────────────────┤

│ Àíòèáèîòèêè <*>:                             │ ïðîäóêòàõ íà 

                                              │ìîëî÷íîé       

                                              │îñíîâå         

├────────────────────────────┼──────────────────┼────────────────┤

│ëåâîìèöåòèí (õëîðàìôåíèêîë) │íå äîïóñêàåòñÿ    │< 0,01         

                                              │< 0,0003       

                                              │ââîäèòñÿ â     

                                              │äåéñòâèå ñ     

                                              │01.01.2012     

├────────────────────────────┼──────────────────┼────────────────┤

│òåòðàöèêëèíîâàÿ ãðóïïà      │íå äîïóñêàåòñÿ    │< 0,01         

├────────────────────────────┼──────────────────┼────────────────┤

│Ïåíèöèëëèíû                 │íå äîïóñêàåòñÿ    │< 0,004        

├────────────────────────────┼──────────────────┼────────────────┤

│Ñòðåïòîìèöèí                │íå äîïóñêàåòñÿ    │< 0,2          

└────────────────────────────┴──────────────────┴────────────────┘

 

7.10.  ïóíêòå 3.5.2 "Êàøè íà ìîëî÷íî-çåðíîâîé îñíîâå (èíñòàíòíîãî ïðèãîòîâëåíèÿ)" ïîäðàçäåë "2) Ïîêàçàòåëè áåçîïàñíîñòè" äîïîëíèòü ïîêàçàòåëåì "Àíòèáèîòèêè" ïåðåä ñòðîêîé "Ïåñòèöèäû <**>:" è èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

 

3.5.2. Êàøè íà ìîëî÷íî-çåðíîâîé îñíîâå (èíñòàíòíîãî ïðèãîòîâëåíèÿ)

 

Ïîêàçàòåëè        

Äîïóñòèìûå óðîâíè,
ìã/êã, íå áîëåå 

Ïðèìå÷àíèÿ   

Ò-2 òîêñèí                 

Íå äîïóñêàåòñÿ   

< 0,05         

Àíòèáèîòèêè <*>:           

ïî ï. 3.5.1      

 

Ïåñòèöèäû <*>:                                                 

 

7.11.  ïðèìå÷àíèè ïîä òàáëèöåé ê ðàçäåëó 3.5 ôðàçû: "<*> Ïðè èñïîëüçîâàíèè õèìè÷åñêèõ ìåòîäîâ îïðåäåëåíèÿ ãðèçèíà, áàöèòðàöèíà, àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû, ïåíèöèëëèíà, ñòðåïòîìèöèíà ïåðåñ÷åò èõ ôàêòè÷åñêîãî ñîäåðæàíèÿ â åä./ã ïðîèçâîäèòñÿ ïî àêòèâíîñòè ñòàíäàðòà." è "<**> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ ïåñòèöèäîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. ï. 3.8, 3.8.1, 4.5.3.1)" çàìåíèòü îäíîé ôðàçîé "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ ïåñòèöèäîâ è àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. ï. 3.12, 3.13, 3.15)".

7.12. Â ðàçäåëå 3.6 "Îñíîâíûå ñûðüå è êîìïîíåíòû, èñïîëüçóåìûå ïðè èçãîòîâëåíèè ïðîäóêòîâ äåòñêîãî ïèòàíèÿ" â ïóíêòàõ 3.6.4, 3.6.4.1, 3.6.5, 3.6.8 â ïîäðàçäåëå "2) Ïîêàçàòåëè áåçîïàñíîñòè" ïîçèöèþ "Àíòèáèîòèêè" è äîïóñòèìûå óðîâíè ïî ãðóïïàì ïðîäóêòîâ èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

 

┌──────────────┬───────────────┬──────────────────┬──────────────┐

│Èíäåêñ, ãðóïïà│  Ïîêàçàòåëè   │Äîïóñòèìûå óðîâíè,│  Ïðèìå÷àíèå 

  ïðîäóêòîâ                 │ ìã/êã, íå áîëåå               

├──────────────┼───────────────┼──────────────────┼──────────────┤

      1              2               3                4     

├──────────────┼───────────────┼──────────────────┼──────────────┤

│3.6.4. Ìÿñî   │Àíòèáèîòèêè    │íå äîïóñêàåòñÿ    │< 0,01       

│óáîéíûõ       │<*>:                             │< 0,0003     

│æèâîòíûõ      │ëåâîìèöåòèí                      │ââîäèòñÿ â   

│(ãîâÿäèíà,    │(õëîðàìôåíèêîë)│                  │äåéñòâèå ñ   

│ñâèíèíà,                                       │01.01.2012   

│êîíèíà è äð.) ├───────────────┼──────────────────┼──────────────┤

              │òåòðàöèêëèíîâàÿ│íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │Áàöèòðàöèí     │íå äîïóñêàåòñÿ    │< 0,02       

├──────────────┼───────────────┼──────────────────┼──────────────┤

│3.6.4.1.      │Àíòèáèîòèêè    │íå äîïóñêàåòñÿ    │< 0,01       

│Ñóáïðîäóêòû   │<*>:                             │< 0,0003     

│óáîéíûõ       │ëåâîìèöåòèí                      │ââîäèòñÿ â   

│æèâîòíûõ      │(õëîðàìôåíèêîë)│                  │äåéñòâèå ñ   

│(ïå÷åíü,                                       │01.01.2012   

│ñåðäöå, ÿçûê) ├───────────────┼──────────────────┼──────────────┤

              │òåòðàöèêëèíîâàÿ│íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │áàöèòðàöèí     │íå äîïóñêàåòñÿ    │< 0,02       

├──────────────┼───────────────┼──────────────────┼──────────────┤

│3.6.5. Ìÿñî   │Àíòèáèîòèêè    │íå äîïóñêàåòñÿ    │< 0,01       

│ïòèöû         │<*>:                             │< 0,0003     

              │ëåâîìèöåòèí                      │ââîäèòñÿ â   

              │(õëîðàìôåíèêîë)│                  │äåéñòâèå ñ   

                                               │01.01.2012   

              ├───────────────┼──────────────────┼──────────────┤

              │òåòðàöèêëèíîâàÿ│íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │áàöèòðàöèí     │íå äîïóñêàåòñÿ    │< 0,02       

├──────────────┼───────────────┴──────────────────┴──────────────┤

│3.6.8. Ìàñëî  │Àíòèáèîòèêè <*>: â òîì ÷èñëå â æèðå ïòè÷üåì     

│êîðîâüå âûñøèé│òîïëåíîì                                         

│ñîðò          ├───────────────┬──────────────────┬──────────────┤

│Æèð ïòè÷èé    │ëåâîìèöåòèí    │íå äîïóñêàåòñÿ    │< 0,01       

│òîïëåíûé      │(õëîðàìôåíèêîë)│                  │< 0,0003     

                                               │ââîäèòñÿ â   

                                               │äåéñòâèå ñ   

                                               │01.01.2012   

              ├───────────────┼──────────────────┼──────────────┤

              │òåòðàöèêëèíîâàÿ│íå äîïóñêàåòñÿ    │< 0,01       

              │ãðóïïà                                        

              ├───────────────┼──────────────────┼──────────────┤

              │ïåíèöèëëèíû    │íå äîïóñêàåòñÿ    │< 0,004       

              ├───────────────┼──────────────────┼──────────────┤

              │ñòðåïòîìèöèí   │íå äîïóñêàåòñÿ    │< 0,2        

└──────────────┴───────────────┴──────────────────┴──────────────┘

 

7.13. Ïóíêò 3.6.6 "Ðûáà" ìåæäó ñòðîêàìè "ðòóòü" è "Ïåñòèöèäû <*>" äîïîëíèòü ñòðîêîé ñ ïîêàçàòåëåì "Àíòèáèîòèêè" è äîïóñòèìûå óðîâíè ïî ãðóïïàì ïðîäóêòîâ èçëîæèòü â ñëåäóþùåé ðåäàêöèè:

 

3.6.6. Ðûáà  

Àíòèáèîòèêè <*>: â ðûáå ïðóäîâîé è ñàäêîâîãî    
ñîäåðæàíèÿ                                      

òåòðàöèêëèíîâàÿ
ãðóïïà        

íå äîïóñêàåòñÿ   

< 0,01       

 

7.14.  ïðèìå÷àíèè ïîä òàáëèöåé ê ðàçäåëó 3.6 ôðàçû: "<*> Ïðè èñïîëüçîâàíèè õèìè÷åñêèõ ìåòîäîâ îïðåäåëåíèÿ ãðèçèíà, áàöèòðàöèíà, àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû, ïåíèöèëëèíà, ñòðåïòîìèöèíà ïåðåñ÷åò èõ ôàêòè÷åñêîãî ñîäåðæàíèÿ â åä./ã ïðîèçâîäèòñÿ ïî àêòèâíîñòè ñòàíäàðòà." è "<**> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ ïåñòèöèäîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. ï. 3.12, 3.13)" çàìåíèòü ôðàçîé "<*> Íåîáõîäèìî êîíòðîëèðîâàòü îñòàòî÷íûå êîëè÷åñòâà è òåõ ïåñòèöèäîâ è àíòèáèîòèêîâ, êîòîðûå áûëè èñïîëüçîâàíû ïðè ïðîèçâîäñòâå ïðîäîâîëüñòâåííîãî ñûðüÿ (ñì. ï. ï. 3.12, 3.13, 3.15)".

8. Äîïîëíèòü Ïðèëîæåíèåì N 19, Ïðèëîæåíèåì N 20 è Ïðèëîæåíèåì N 21 â ñëåäóþùåé ðåäàêöèè:

 

"Ïðèëîæåíèå N 19

ê ÑàíÏèÍ 2.3.2.2804-10

 

ÏÅÐÅ×ÅÍÜ

ÏÈÙÅÂÛÕ ÏÐÎÄÓÊÒÎÂ, ÐÅÊÎÌÅÍÄÓÅÌÛÕ Ê ÎÁÎÃÀÙÅÍÈÞ ÂÈÒÀÌÈÍÀÌÈ

È ÌÈÍÅÐÀËÜÍÛÌÈ ÂÅÙÅÑÒÂÀÌÈ

 

┌─────────────────────────────┬───────────────────────────────────────────┐

  Ãðóïïà ïèùåâûõ ïðîäóêòîâ   │Ìèêðîíóòðèåíò, ðåêîìåíäóåìûé äëÿ îáîãàùåíèÿ│

├─────────────────────────────┼───────────────────────────────────────────┤

              1                                   2                    

├─────────────────────────────┼───────────────────────────────────────────┤

│1. Ìóêà ïøåíè÷íàÿ âûñøåãî è  │Âèòàìèíû: B1, B2, B6, PP, ôîëèåâàÿ êèñëîòà,│

│ïåðâîãî ñîðòà                │C (òåõíîëîãè÷åñêàÿ äîáàâêà)               

                             │Ìèíåðàëüíûå âåùåñòâà: æåëåçî, êàëüöèé      

├─────────────────────────────┼───────────────────────────────────────────┤

│2. Õëåá è õëåáîáóëî÷íûå      │Âèòàìèíû: B1, B2, B6, PP, ôîëèåâàÿ êèñëîòà,│

│èçäåëèÿ                      │áåòà-êàðîòèí                              

                             │Ìèíåðàëüíûå âåùåñòâà: æåëåçî, êàëüöèé, éîä │

├─────────────────────────────┼───────────────────────────────────────────┤

│3. Ìîëî÷íàÿ ïðîäóêöèÿ        │Âèòàìèíû: C, A, E, D, K, áåòà-êàðîòèí, B1, │

│(ìîëî÷íûé ïðîäóêò, ìîëî÷íûé  │B2, B6, PP, B12, ôîëèåâàÿ êèñëîòà,        

│ñîñòàâíîé ïðîäóêò,           │ïàíòîòåíîâàÿ êèñëîòà, áèîòèí              

│ìîëîêîñîäåðæàùèé ïðîäóêò,    │Ìèíåðàëüíûå âåùåñòâà: æåëåçî, êàëüöèé, éîä │

│ïðîäóêò ïåðåðàáîòêè ìîëîêà)                                            

├─────────────────────────────┼───────────────────────────────────────────┤

│4. Íàïèòêè áåçàëêîãîëüíûå    │Âèòàìèíû: C, A, E, D, K, áåòà-êàðîòèí è   

                             │äðóãèå êàðîòèíîèäû, B1, B2, B6, PP, B12,  

                             │ôîëèåâàÿ êèñëîòà, ïàíòîòåíîâàÿ êèñëîòà,   

                             │áèîòèí                                    

                             │Ìèíåðàëüíûå âåùåñòâà: éîä, æåëåçî, êàëüöèé │

├─────────────────────────────┼───────────────────────────────────────────┤

│5. Ñîêîâàÿ ïðîäóêöèÿ èç      │Âèòàìèíû: C, A, E, áåòà-êàðîòèí, B1, B2,  

│ôðóêòîâ (âêëþ÷àÿ ÿãîäû) è    │B6, PP, ôîëèåâàÿ êèñëîòà                  

│îâîùåé (ñîêè, ôðóêòîâûå è    │Ìèíåðàëüíûå âåùåñòâà: éîä, æåëåçî, êàëüöèé │

│(èëè) îâîùíûå íåêòàðû,                                                 

│ôðóêòîâûå è (èëè) îâîùíûå                                              

│ñîêîñîäåðæàùèå íàïèòêè)                                                

├─────────────────────────────┼───────────────────────────────────────────┤

│6. Çåðíîâûå ïðîäóêòû (ãîòîâûå│Âèòàìèíû: C, A, E, D, áåòà-êàðîòèí, B1, B2,│

│çàâòðàêè, ãîòîâûå ê          │B6, PP, B12, ôîëèåâàÿ êèñëîòà, ïàíòîòåíîâàÿ│

│óïîòðåáëåíèþ ýêñòðóäèðîâàííûå│êèñëîòà, áèîòèí                            

│ïðîäóêòû, ìàêàðîííûå è       │Ìèíåðàëüíûå âåùåñòâà: æåëåçî, êàëüöèé, éîä │

│êðóïÿíûå èçäåëèÿ áûñòðîãî                                              

│ïðèãîòîâëåíèÿ)                                                         

├─────────────────────────────┼───────────────────────────────────────────┤

│7. Ìàñëîæèðîâàÿ ïðîäóêöèÿ    │Âèòàìèíû: A, E, D, áåòà-êàðîòèí           

│(ìàñëà ðàñòèòåëüíûå,                                                   

│ìàðãàðèíû, ñïðåäû, ìàéîíåçû, │                                           

│ñîóñû)                                                                 

├─────────────────────────────┼───────────────────────────────────────────┤

│8. Ïèùåâûå êîíöåíòðàòû       │Âèòàìèíû: C, A, E, D, K, áåòà-êàðîòèí, B1, │

│(êèñåëè, íàïèòêè áûñòðîãî    │B2, B6, PP, B12, ôîëèåâàÿ êèñëîòà,        

│ïðèãîòîâëåíèÿ, áëþäà, íå     │ïàíòîòåíîâàÿ êèñëîòà, áèîòèí              

│òðåáóþùèå âàðêè)             │Ìèíåðàëüíûå âåùåñòâà: éîä, æåëåçî, êàëüöèé,│

                             │ìàãíèé, êàëèé                             

├─────────────────────────────┼───────────────────────────────────────────┤

│9. Êîíäèòåðñêèå èçäåëèÿ      │Âèòàìèíû: C, A, E, áåòà-êàðîòèí, B1, B2,  

                             │B6, PP, ôîëèåâàÿ êèñëîòà                   

                             │Ìèíåðàëüíûå âåùåñòâà: éîä, æåëåçî, êàëüöèé,│

                             │ìàãíèé                                    

├─────────────────────────────┼───────────────────────────────────────────┤

│10. Êîíöåíòðàòû ïëîäîâî-     │Âèòàìèíû: C, A, E, áåòà-êàðîòèí, B1, B2,  

│ÿãîäíûå ñ äîáàâëåíèåì ñàõàðà │B6, PP, ôîëèåâàÿ êèñëîòà                  

│èëè äðóãèõ ïîäñëàùèâàþùèõ    │Ìèíåðàëüíûå âåùåñòâà: éîä, æåëåçî, êàëüöèé │

│âåùåñòâ (âàðåíüå, äæåì,                                                 

│êîíôèòþð, æåëå, ôðóêòîâîå                                              

│ìîðîæåíîå è äð.)                                                       

├─────────────────────────────┼───────────────────────────────────────────┤

│12. Ñîëü ïèùåâàÿ ïîâàðåííàÿ  │Ìèíåðàëüíûå âåùåñòâà: éîä, ôòîð <*>, êàëèé,│

                             │ìàãíèé                                    

└─────────────────────────────┴───────────────────────────────────────────┘

 

--------------------------------

<*> Äëÿ òåððèòîðèé ñ äåôèöèòîì ýòîãî ìèêðîýëåìåíòà.

 

 

 

 

 

Ïðèëîæåíèå N 20

ê ÑàíÏèÍ 2.3.2.2804-10

 

ÊÐÈÒÅÐÈÈ

ÎÒÍÅÑÅÍÈß ÏÈÙÅÂÎÃÎ ÏÐÎÄÓÊÒÀ Ê ÊÀÒÅÃÎÐÈÈ ÎÁÎÃÀÙÅÍÍÛÕ

ÂÈÒÀÌÈÍÀÌÈ È/ÈËÈ ÌÈÍÅÐÀËÜÍÛÌÈ ÂÅÙÅÑÒÂÀÌÈ ÏÈÙÅÂÛÕ ÏÐÎÄÓÊÒÎÂ

 

Ãðóïïà ïèùåâûõ ïðîäóêòîâ        

Ìàññà (îáúåì) ïèùåâîãî    
ïðîäóêòà, â êîòîðîé äîëæíî  
ñîäåðæàòüñÿ íå ìåíåå ÷åì 15% è
íå áîëåå ÷åì 50% îò íîðì   
ôèçèîëîãè÷åñêîé ïîòðåáíîñòè â
ìèêðîíóòðèåíòå        

Ìóêà ïøåíè÷íàÿ âûñøåãî è ïåðâîãî ñîðòà  

100 ã            

Õëåá è õëåáîáóëî÷íûå èçäåëèÿ èç ïøåíè÷íîé
ìóêè âûñøåãî è ïåðâîãî ñîðòà è ðæàíî-   
ïøåíè÷íîé ìóêè                          

150 ã            

Ìîëî÷íàÿ ïðîäóêöèÿ æèäêàÿ, ïðîäóêòû     
áåëêîâûå èç ñåìÿí çåðíîâûõ, çåðíîáîáîâûõ
è äð. êóëüòóð æèäêèå (ñîåâîå ìîëîêî)    

200 ìë            

Ìîëî÷íàÿ ïðîäóêöèÿ è ïðîäóêòû áåëêîâûå èç
ñåìÿí çåðíîâûõ, çåðíîáîáîâûõ è äð.      
êóëüòóð (òîôó) òâåðäûå è ïàñòîîáðàçíûå  

100 ã            

Ñîêîâàÿ ïðîäóêöèÿ èç ôðóêòîâ (âêëþ÷àÿ   
ÿãîäû) è (èëè) îâîùåé, íàïèòêè           
áåçàëêîãîëüíûå, â ò.÷. ïðèãîòîâëåííûå èç
ïèùåâûõ êîíöåíòðàòîâ                    

300 ìë            

Çåðíîâûå ïðîäóêòû ñóõèå (ãîòîâûå        
çàâòðàêè, ãîòîâûå ê óïîòðåáëåíèþ        
ýêñòðóäèðîâàííûå ïðîäóêòû, ìàêàðîííûå è 
êðóïÿíûå èçäåëèÿ áûñòðîãî ïðèãîòîâëåíèÿ,
íå òðåáóþùèå âàðêè)                     

50 ã             

Ìàñëîæèðîâàÿ ïðîäóêöèÿ, êîíäèòåðñêèå    
èçäåëèÿ, ñûðû ñû÷óæíûå òâåðäûå, êîíñåðâû
è êîíöåíòðàòû îâîùíûå, ôðóêòîâûå, ÿãîäíûå
è ïèùåâûå êîíöåíòðàòû                   

Íà 100 êêàë         

Ñîëü ïèùåâàÿ ïîâàðåííàÿ éîäèðîâàííàÿ    

1 - 2 ã           

Ñîëü ïèùåâàÿ ïîâàðåííàÿ                 

5 ã             

 


 

Ïðèëîæåíèå N 21

ê ÑàíÏèÍ 2.3.2.2804-10

 

"ÌÀÊÑÈÌÀËÜÍÛÅ ÄÎÏÓÑÒÈÌÛÅ ÓÐÎÂÍÈ

ÎÑÒÀÒÊΠÂÅÒÅÐÈÍÀÐÍÛÕ (ÇÎÎÒÅÕÍÈ×ÅÑÊÈÕ) ÏÐÅÏÀÐÀÒΠ ÏÈÙÅÂÛÕ

ÏÐÎÄÓÊÒÀÕ ÆÈÂÎÒÍÎÃÎ ÏÐÎÈÑÕÎÆÄÅÍÈß, ÊÎÍÒÐÎËÈÐÓÅÌÛÅ ÑÎÃËÀÑÍÎ

ÈÍÔÎÐÌÀÖÈÈ ÎÁ ÈÕ ÈÑÏÎËÜÇÎÂÀÍÈÈ ÏÐÈ ÏÐÎÈÇÂÎÄÑÒÂÅ

ÏÐÎÄÎÂÎËÜÑÒÂÅÍÍÎÃÎ ÑÛÐÜß"

 

┌──────┬───────────────────┬────────────────────┬─────────────┬──────────┬────────────────────┐

│Èíäåêñ│Íàçâàíèå ïðåïàðàòîâ│        Âèä         │Íàèìåíîâàíèå │Ìàêñè-         Ïðèìå÷àíèÿ    

                         │ñåëüñêîõîçÿéñòâåííûõ│  ïðîäóêòà   │ìàëüíûå                      

                               æèâîòíûõ                   │óðîâíè                       

                                                          │îñòàòêîâ                     

                                                          │(ìã/êã, íå│                   

                                                          │áîëåå) <*>│                   

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

  1            2                  3                4          5              6         

├──────┼───────────────────┴────────────────────┴─────────────┴──────────┼────────────────────┤

│1.    │Àíòèìèêðîáíûå ñðåäñòâà <**>                                                         

├──────┼───────────────────┬────────────────────┬─────────────┬──────────┼────────────────────┤

│1.1   │Àïðàìèöèí          │âñå âèäû óáîéíûõ    │Ìÿñî, æèð    │1                            

      │Apramicin          │æèâîòíûõ è ïòèöû    ├─────────────┼──────────┤                   

      │(àìèíîãëèêîçèäû)                       │ïå÷åíü       │10                           

                                             ├─────────────┼──────────┤                   

                                             │ïî÷êè        │20                           

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.2   │Ãåíòàìèöèí         │âñå âèäû óáîéíûõ    │Ìÿñî, æèð    │0,05                         

      │Gentamycin         │æèâîòíûõ            ├─────────────┼──────────┤                   

      │(àìèíîãëèêîçèäû)                       │ïå÷åíü       │0,2                          

                                             ├─────────────┼──────────┤                   

                                             │ïî÷êè        │0,75                         

                         ├────────────────────┼─────────────┼──────────┤                   

                         │êðóïíûé ðîãàòûé ñêîò│Ìîëîêî       │0,1                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.3   │Êàíàìèöèí          │Âñå âèäû óáîéíûõ    │Ìÿñî, æèð    │0,1                          

      │Kanamycin          │æèâîòíûõ è ïòèöû, çà├─────────────┼──────────┤                   

      │(àìèíîãëèêîçèäû)   │èñêëþ÷åíèåì ðûáû    │ïå÷åíü       │0,6                          

                                             ├─────────────┼──────────┤                   

                                             │ïî÷êè        │2,5                          

                                             ├─────────────┼──────────┤                   

                                             │Ìîëîêî       │0,15                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.4   │Íåîìèöèí           │Âñå âèäû óáîéíûõ    │Ìÿñî, æèð    │0,5       │Âêëþ÷àÿ            

                         │æèâîòíûõ, â òîì     ├─────────────┼──────────┤ôðàìèöåòèí         

                         │÷èñëå ïòèöà è ðûáà  │ßéöà è æèäêèå│0,5                          

                         │ïðóäîâàÿ è ñàäêîâîãî│ÿè÷íûå                                    

                         │ñîäåðæàíèÿ          │ïðîäóêòû                                  

                                             ├─────────────┼──────────┤                   

                                             │Ïî÷êè        │5                            

                                             ├─────────────┼──────────┤                   

                                             │ïå÷åíü       │0,5                          

                                             ├─────────────┼──────────┤                   

                                             │Ìîëîêî       │1,5                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.6   │Ïàðîìîìèöèí        │Âñå âèäû óáîéíûõ    │Ìÿñî         │0,5                          

      │Paromomycin        │æèâîòíûõ, â òîì     ├─────────────┼──────────┤                   

      │(àìèíîãëèêîçèäû)   │÷èñëå ïòèöà è ðûáà  │Ïå÷åíü è     │1,5                          

                         │ïðóäîâàÿ è ñàäêîâîãî│ïî÷êè                                     

                         │ñîäåðæàíèÿ                                                    

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.7   │Ñïåêòèíîìèöèí      │Âñå âèäû óáîéíûõ    │Æèð          │0,5                          

      │Spectinomycin      │æèâîòíûõ, â òîì     ├─────────────┼──────────┤                   

      │(àìèíîãëèêîçèäû)   │÷èñëå ïòèöà è ðûáà  │Ìÿñî         │0,3                          

                         │ïðóäîâàÿ è ñàäêîâîãî├─────────────┼──────────┤                   

                         │ñîäåðæàíèÿ, çà      │Ïî÷êè        │5                            

                         │èñêëþ÷åíèåì îâåö    ├─────────────┼──────────┤                   

                                             │Ïå÷åíü       │1                            

                                             │ãîâÿæüÿ                                   

                                             ├─────────────┼──────────┤                   

                                             │Ìîëîêî       │0,2                          

                                                                                       

                         │Îâöû                │Æèð          │0,5                          

                                             ├─────────────┼──────────┤                   

                                             │Ìÿñî         │0,3                          

                                             ├─────────────┼──────────┤                   

                                             │Ïî÷êè        │5                            

                                             ├─────────────┼──────────┤                   

                                             │Ïå÷åíü       │2                            

                                             ├─────────────┼──────────┤                   

                                             │Ìîëîêî       │0,2                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.8   │Ñòðåïòîìèöèí/      │Âñå âèäû óáîéíûõ    │Ìÿñî         │0,5                          

      │Äèãèäðîñòðåïòîìèöèí│æèâîòíûõ            │Æèð          │0,5                          

      │Streptomycin/                          │Ïå÷åíü       │0,5                          

      │Dihydrostreptomycin│                    │Ïî÷êè        │1                            

      │(àìèíîãëèêîçèäû)   ├────────────────────┼─────────────┼──────────┤                   

                         │Ïòèöà               │ßéöà è ÿè÷íûå│0,5                          

                                             │ïðîäóêòû                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.9   │Öåôòèîôóð          │Âñå âèäû óáîéíûõ    │ìÿñî         │1,0       │Ñóììà âñåõ îñòàòêîâ,│

      │Ceftiofur          │ìëåêîïèòàþùèõ       │ïå÷åíü       │2,0       │ñîäåðæàùèõ         

      │(öåôàëîñïîðèíû)    │æèâîòíûõ, ïòèöà     │ïî÷êè        │6,0       │áåòà-ëàêòàìîâóþ    

                                             │æèð          │2,0       │ñòðóêòóðó,         

                                             │ìîëîêî       │0,1       │âûðàæåííûõ êàê     

                                                                    │äåñôóðîèë-öåôòèîôóð │

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.10  │Öåôàöåòðèë         │êðóïíûé ðîãàòûé ñêîò│Ìîëîêî       │0,125     │Ïðè âíóòðèâûìåííîì 

      │Cefacetrile                                                   │èñïîëüçîâàíèè      

      │(öåôàëîñïîðèíû)                                                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.11  │Öåôàëåêñèí         │êðóïíûé ðîãàòûé ñêîò│Ìîëîêî       │0,1                          

      │Cefalexin                              │Ìÿñî         │0,2                          

      │(öåôàëîñïîðèíû)                        │Æèð          │0,2                          

                                             │Ïî÷êè        │1                            

                                             │ïå÷åíü       │0,2                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.12  │Öåôàëîíèì          │êðóïíûé ðîãàòûé ñêîò│ìîëîêî       │0,02                         

      │Cefalonium                                                                       

      │(öåôàëîñïîðèíû)                                                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.13  │Öåôîïåðàçîí        │êðóïíûé ðîãàòûé ñêîò│Ìîëîêî       │0,05                         

      │Cefoperazone                                                                     

      │(öåôàëîñïîðèíû)                                                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.14  │Öåôêèíîì           │êðóïíûé ðîãàòûé     │Ìÿñî,        │0,05                         

      │Cefquinome         │ñêîò, ñâèíüè, ëîøàäè│êîæà,        │0,05                         

      │(öåôàëîñïîðèíû)                        │æèð,         │0,05                         

                                             │ïå÷åíü       │0,1                          

                                             │ïî÷êè        │0,2                          

                                             ├─────────────┼──────────┤                   

                                             │ìîëîêî       │0,02                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┤                   

│1.15  │Öåôàïèðèí          │êðóïíûé ðîãàòûé ñêîò│Ìÿñî,        │0,05      │Ñóììà              

      │Cefapirin                              │æèð          │0,05      │öåôàïèðèíà è       

      │(öåôàëîñïîðèíû)                        ├─────────────┼──────────┤äåçàöåòèë-öåôàïèðèíà│

                                             │ïî÷êè        │0,1                          

                                             ├─────────────┼──────────┤                   

                                             │Ìîëîêî       │0,01                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.16. │Âñå âåùåñòâà       │Âñå âèäû óáîéíûõ    │Ìÿñî,        │0,1       │Ñóììà âñåõ îñòàòêîâ │

      │ñóëüôàíèëàìèäíîé   │æèâîòíûõ è ïòèöû    │æèð,         │0,1       │äàííîé ãðóïïû íå   

      │ãðóïïû                                 │ïå÷åíü,      │0,1       │äîëæíà ïðåâûøàòü ÌÄÓ│

      │(ñóëüôàíèëàìèäû)                       │ïî÷êè        │0,1                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Êðóïíûé ðîãàòûé ñêîò│Ìîëîêî       │0,025                        

                         │Îâöû                                                          

                         │Êîçû                                                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.17. │Áàêâèëîïðèì        │Êðóïíûé ðîãàòûé ñêîò│æèð          │0,01                         

      │Baquiloprim                            │ïå÷åíü       │0,3                          

      │(ïðîèçâîäíûå                           │ïî÷êè        │0,15                         

      │äèàìèíîïèðèìèäèíà) │                    │ìîëîêî       │0,03                         

                                                                                       

                         │ñâèíüè              │êîæà è æèð   │0,04                         

                                             │ïå÷åíü       │0,05                         

                                             │ïî÷êè        │0,05                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.18. │Òðèìåòîïðèì        │Âñå âèäû óáîéíûõ    │ìÿñî         │0,05                         

      │Trimethoprim       │æèâîòíûõ è ïòèöû, çà│ïå÷åíü       │0,05                         

      │(ïðîèçâîäíûå       │èñêëþ÷åíèåì ëîøàäåé │ïî÷êè        │0,05                         

      │äèàìèíîïèðèìèäèíà) │                    │æèð          │0,05                         

                                             ├─────────────┼──────────┤                   

                                             │ìîëîêî       │0,05                         

                                             ├─────────────┼──────────┤                   

                         │Ëîøàäè              │ìÿñî         │0,1                          

                                             │ïå÷åíü       │0,1                          

                                             │ïî÷êè        │0,1                          

                                             │æèð          │0,1                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.19. │Êëàâóëàíîâàÿ       │Êðóïíûé ðîãàòûé     │Ìÿñî         │0,1                          

      │êèñëîòà            │ñêîò, ñâèíüè        │Æèð (äëÿ     │0,1                          

      │Clavulanic acid                        │ñâèíåé êîæà è│                             

      │(èíãèáèòîðû                            │æèð)                                      

      │áåòàëàêòàìàçû)                         │ïå÷åíü       │0,2                          

                                             │ïî÷êè        │0,4                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Êðóïíûé ðîãàòûé ñêîò│ìîëîêî       │0,2                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.20  │Ëèíêîìèöèí/        │Âñå âèäû óáîéíûõ    │ìÿñî         │0,1                          

      │êëèíäàìèöèí        │æèâîòíûõ è ïòèöû    ├─────────────┼──────────┤                   

      │Lincomycin/                            │æèð, êîæà    │0,05                         

      │Clindamycin                            ├─────────────┼──────────┤                   

      │(ëèíêîçàìèäû)                          │ïå÷åíü       │0,5                          

                                             ├─────────────┼──────────┤                   

                                             │ïî÷êè        │1,5                          

                                             │ìîëîêî       │0,15                         

                                             │ÿéöà è æèäêèå│0,05                         

                                             │ÿè÷íûå                                    

                                             │ïðîäóêòû                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.21  │Ïèðëèìèöèí         │âñå âèäû óáîéíûõ    │ìÿñî         │0,1                          

      │Pirlimycin         │æèâîòíûõ è ïòèöû    ├─────────────┼──────────┤                   

      │(ëèíêîçàìèäû)                          │ïå÷åíü       │1                            

                                             ├─────────────┼──────────┤                   

                                             │ïî÷êè        │0,4                          

                                             │ìîëîêî       │0,1                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.22  │Òèàìôåíèêîë        │âñå âèäû óáîéíûõ    │ìÿñî (äëÿ    │0,05      │êàê ñóììà          

      │Thiamphenicol      │æèâîòíûõ, â òîì     │ðûáû                   │òèàìôåíèêîëà è     

      │(ôëîðôåíèêîëû)     │÷èñëå ïòèöà è ðûáà  │â íàòóðàëüíîé│          │êîíüþãàòîâ         

                         │ïðóäîâàÿ è ñàäêîâîãî│ïðîïîðöèè ñ            │òèàìôåíèêîëà â     

                         │ñîäåðæàíèÿ          │êîæåé)                 │ðàñ÷åòå íà         

                                             │ïå÷åíü (êðîìå│0,05      │òèàìôåíèêîë        

                                             │ðûáû)                                     

                                             │ïî÷êè (êðîìå │0,05                         

                                             │ðûáû)                                     

                                             │æèð (äëÿ     │0,05                         

                                             │ñâèíåé è                                  

                                             │ïòèöû â                                   

                                             │íàòóðàëüíûõ                               

                                             │ïðîïîðöèÿõ ñ │                             

                                             │êîæåé)                                    

                                             │ìîëîêî       │0,05                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.23  │Ôëîðôåíèêîë        │Êðóïíûé è ìåëêèé    │ìÿñî         │0,2       │Ñóììà              

      │Florfenicol        │ðîãàòûé ñêîò        │ïå÷åíü       │3         │ôëîðôåíèêîëà è åãî 

      │(ôëîðôåíèêîëû)                         │æèð          │0,2       │ìåòàáîëèòîâ â âèäå 

                                             │ïî÷êè        │0,3       │ôëîðôåíèêîëàìèíà   

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ñâèíüè              │ìÿñî         │0,3                          

                                             │ïå÷åíü       │2                            

                                             │ïî÷êè        │0,5                          

                                             │æèð, êîæà    │0,5                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ïòèöà               │ìÿñî         │0,1                          

                         ├────────────────────┼─────────────┼──────────┤                   

                                             │ïå÷åíü       │2,5                          

                                             ├─────────────┼──────────┤                   

                                             │ïî÷êè        │0,75                         

                                             ├─────────────┼──────────┤                   

                                             │æèð, êîæà    │0,2                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ðûáà ïðóäîâàÿ è     │ìÿñî (â      │1                            

                         │ñàäêîâîãî ñîäåðæàíèÿ│íàòóðàëüíîé                               

                                             │ïðîïîðöèè ñ                               

                                             │êîæåé)                                    

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Äðóãèå âèäû æèâîòíûõ│ìÿñî         │0,1                          

                                             ├─────────────┼──────────┤                   

                                             │æèð          │0,2                          

                                             ├─────────────┼──────────┤                   

                                             │ïå÷åíü       │2                            

                                             ├─────────────┼──────────┤                   

                                             │ïî÷êè        │0,3                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.24  │Ôëóìåêâèí          │Êðóïíûé è ìåëêèé    │ìÿñî         │0,2                          

      │Flumequine         │ðîãàòûé ñêîò, ñâèíüè│ïå÷åíü       │0,5                          

      │(õèíîëîíû)                             │ïî÷êè        │1,5                          

                                             │æèð          │0,3                          

                                             │ìîëîêî       │0,05                         

                                             ├─────────────┼──────────┤                   

                         │Ïòèöà               │ìÿñî         │0,4                          

                                             │ïå÷åíü       │0,8                          

                                             │ïî÷êè        │1                            

                                             │æèð, êîæà    │0,25                         

                                             ├─────────────┼──────────┤                   

                         │Ðûáà ïðóäîâàÿ è     │ìÿñî (â      │0,6                          

                         │ñàäêîâîãî           │íàòóðàëüíîé                               

                         │ñîäåðæàíèÿ          │ïðîïîðöèè ñ                               

                                             │êîæåé)                                    

                                             ├─────────────┼──────────┤                   

                         │Äðóãèå âèäû æèâîòíûõ│ìÿñî         │0,2                          

                                             │ïå÷åíü       │0,5                          

                                             │ïî÷êè        │1                            

                                             │æèð          │0,25                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.25  │Öèïðîôëîêñàöèí/    │Âñå âèäû óáîéíûõ    │Ìÿñî         │0,1       │Ñóììà ôòîðõèíîëîíîâ │

      │ýíðîôëîêñàöèí      │æèâîòíûõ, â òîì     │Æèð (äëÿ     │0,1                          

      │/Ïåôëîêñàöèí/      │÷èñëå ïòèöà è ðûáà  │ñâèíåé â                                  

      │îôëîêñàöèí/        │ïðóäîâàÿ è ñàäêîâîãî│íàòóðàëüíîé                               

      │íîðôëîêñàöèí       │ñîäåðæàíèÿ          │ïðîïîðöèè ñ                               

      │Ciprofloxacin/                         │êîæåé)                                    

      │Enrofloxacin/                          ├─────────────┼──────────┤                   

      │pefloxacin/        │Êðóïíûé è ìåëêèé    │Ìîëîêî       │0,1                          

      │ofloxacin/         │ðîãàòûé ñêîò        │Ïå÷åíü       │0,3                          

      │norfloxacin                            │Ïî÷êè        │0,2                          

      │(ôòîðõèíîëîíû)                         ├─────────────┼──────────┤                   

                         │Ïòèöà               │Ïå÷åíü       │0,2                          

                                             │Ïî÷êè        │0,3                          

                                             │Êîæà         │0,1                          

                                             ├─────────────┼──────────┤                   

                         │Ñâèíüè, êðîëèêè     │Ïå÷åíü       │0,2                          

                                             │Ïî÷êè        │0,3                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.26  │Ñàðàôëîêñàöèí      │èíäåéêè, êóðû       │Ìÿñî         │0,01                         

      │Sarafloxacin                           │Ïå÷åíü       │0,1                          

      │(õèíîëîíû)                             │Ïî÷êè        │0,1                          

                                             │Êîæà è æèð   │0,01                         

                                             ├─────────────┼──────────┤                   

                         │ðûáà ïðóäîâàÿ è     │ìÿñî (â      │0,03                         

                         │ñàäêîâîãî ñîäåðæàíèÿ│íàòóðàëüíîé                               

                         │(ëîñîñåâûå)         │ïðîïîðöèè ñ                               

                                             │êîæåé)                                    

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.27  │Äàíîôëîêñàöèí      │Êðóïíûé è ìåëêèé    │Ìÿñî         │0,2                          

      │Danofloxacin       │ðîãàòûé ñêîò, ïòèöà │Ïå÷åíü       │0,4                          

      │(õèíîëîíû)                             │Ïî÷êè        │0,4                          

                                             │Æèð (äëÿ     │0,1                          

                                             │ïòèöû êîæà è │                             

                                             │æèð)                                      

                                             │Ìîëîêî       │0,03                         

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ïðî÷èå âèäû óáîéíûõ │Ìÿñî (äëÿ    │0,1                          

                         │æèâîòíûõ, â òîì     │ðûáû â                                    

                         │÷èñëå ðûáà ïðóäîâàÿ │íàòóðàëüíîé                               

                         │è ñàäêîâîãî         │ïðîïîðöèè ñ                               

                         │ñîäåðæàíèÿ          │êîæåé)                                    

                                             │Ïå÷åíü       │0,2                          

                                             │Ïî÷êè        │0,2                          

                                             │Æèð (äëÿ     │0,05                         

                                             │ñâèíåé â                                  

                                             │íàòóðàëüíîé                               

                                             │ïðîïîðöèè ñ                               

                                             │êîæåé)                                    

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.28. │Äèôëîêñàöèí        │Êðóïíûé è ìåëêèé    │Ìÿñî         │0,4                          

      │Difloxacin         │ðîãàòûé ñêîò        │Ïå÷åíü       │1,4                          

      │(õèíîëîíû)                             │Ïî÷êè        │0,8                          

                                             │Æèð          │0,1                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ñâèíüè              │Ìÿñî         │0,4                          

                                             │Ïå÷åíü       │0,8                          

                                             │Ïî÷êè        │0,8                          

                                             │Êîæà è æèð   │0,1                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ïòèöà               │Ìÿñî         │0,3                          

                                             │Ïå÷åíü       │1,9                          

                                             │Ïî÷êè        │0,6                          

                                             │Êîæà è æèð   │0,4                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ïðî÷èå âèäû óáîéíûõ │Ìÿñî (äëÿ    │0,3                          

                         │æèâîòíûõ, â òîì     │ðûáû â                                    

                         │÷èñëå ðûáà ïðóäîâàÿ │íàòóðàëüíîé                               

                         │è ñàäêîâîãî         │ïðîïîðöèè ñ                               

                         │ñîäåðæàíèÿ          │êîæåé)                                    

                                             │Ïå÷åíü       │0,8                          

                                             │Ïî÷êè        │0,6                          

                                             │Æèð          │0,1                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.29. │Ìàðáîôëîêñàöèí     │Êðóïíûé ðîãàòûé     │Ìÿñî         │0,15                         

      │Marbofloxacin      │ñêîò, ñâèíüè        │Æèð (äëÿ     │0,05                         

      │(õèíîëîíû)                             │ñâèíåé æèð â │                             

                                             │íàòóðàëüíîé                               

                                             │ïðîïîðöèè ñ                               

                                             │êîæåé)                                    

                                             │Ïå÷åíü       │0,15                         

                                             │Ïî÷êè        │0,15                         

                                             │Ìîëîêî       │0,075                        

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.30  │Îêñîëèíîâàÿ êèñëîòà│Âñå âèäû óáîéíûõ    │Ìÿñî (äëÿ    │0,1                          

      │Oxolinic acid      │æèâîòíûõ, â òîì     │ðûáû â                                    

      │(õèíîëîíû)         │÷èñëå ïòèöà è ðûáà  │íàòóðàëüíîé                               

                         │ïðóäîâàÿ è ñàäêîâîãî│ïðîïîðöèè ñ                               

                         │ñîäåðæàíèÿ          │êîæåé)                                    

                                             │Ïå÷åíü       │0,15                         

                                             │Ïî÷êè        │0,15                         

                                             │Æèð (äëÿ     │0,05                         

                                             │ñâèíåé è                                  

                                             │ïòèöû                                     

                                             │êîæà è æèð â │                             

                                             │åñòåñòâåííûõ │                             

                                             │ïðîïîðöèÿõ)                               

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.31  │Ýðèòðîìèöèí        │Âñå âèäû óáîéíûõ    │Ìÿñî (äëÿ    │0,2                          

      │Erythromycin       │æèâîòíûõ, â òîì     │ðûáû â                                    

      │(ìàêðîëèäû)        │÷èñëå ïòèöà è ðûáà  │åñòåñòâåííîé │                             

                         │ïðóäîâàÿ è ñàäêîâîãî│ïðîïîðöèè ñ                               

                         │ñîäåðæàíèÿ          │êîæåé)                                    

                                             ├─────────────┼──────────┤                   

                                             │Ïå÷åíü       │0,2                          

                                             ├─────────────┼──────────┤                   

                                             │Ïî÷êè        │0,2                          

                                             ├─────────────┼──────────┤                   

                                             │Æèð (äëÿ     │0,2                          

                                             │ñâèíåé â                                  

                                             │åñòåñòâåííûõ │                             

                                             │ïðîïîðöèÿõ ñ │                             

                                             │êîæåé)                                    

                                             ├─────────────┼──────────┤                   

                                             │Ìîëîêî       │0,04                         

                                             ├─────────────┼──────────┤                   

                                             │ßéöà è æèäêèå│0,15                         

                                             │ÿè÷íûå                                    

                                             │ïðîäóêòû                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.32  │Ñïèðàìèöèí         │Êðóïíûé ðîãàòûé ñêîò│Ìÿñî         │0,2       │Ñóììà ñïèðàìèöèíà è │

      │Spiramycin                             │Æèð          │0,3       │íåîñïèðàìèöèíà     

      │(ìàêðîëèäû)                            │Ïå÷åíü       │0,3                          

                                             │Ïî÷êè        │0,3                          

                                             │Ìîëîêî       │0,2                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Êóðû                │Ìÿñî         │0,2                          

                                             │Êîæà è æèð   │0,3                          

                                             │Ïå÷åíü       │0,4                          

                         ├────────────────────┼─────────────┼──────────┼────────────────────┤

                         │Ñâèíüè              │Ìÿñî         │0,25      │ýêâèâàëåíòû        

                                             │Ïå÷åíü       │2         │ñïèðàìèöèíà        

                                             │Ïî÷êè        │1         │(îñòàòêè ñ         

                                             │Æèð          │0,3       │àíòèìèêðîáíîé      

                                                                    │àêòèâíîñòüþ)       

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.33  │Òèëìèêîçèí         │Ïòèöà               │Ìÿñî         │0,075                        

      │Tilmicosin                             │êîæà è æèð   │0,075                        

      │(ìàêðîëèäû)                            ├─────────────┼──────────┤                   

                                             │ïå÷åíü       │1                            

                                             ├─────────────┼──────────┤                   

                                             │ïî÷êè        │0,25                         

                         ├────────────────────┼─────────────┼──────────┼────────────────────┤

                         │Ïðî÷èå âèäû óáîéíûõ │Ìÿñî (äëÿ    │0,05                         

                         │æèâîòíûõ, â òîì     │ðûáû â                                    

                         │÷èñëå ðûáà ïðóäîâàÿ │íàòóðàëüíîé                               

                         │è ñàäêîâîãî         │ïðîïîðöèè ñ                               

                         │ñîäåðæàíèÿ          │êîæåé)                                    

                                             │Ïå÷åíü       │1                            

                                             │Ïî÷êè        │1                            

                                             │Æèð (äëÿ     │0,05                         

                                             │ñâèíåé â                                  

                                             │íàòóðàëüíîé                               

                                             │ïðîïîðöèè ñ                               

                                             │êîæåé)                                    

                                             ├─────────────┼──────────┤                   

                                             │Ìîëîêî       │0,05                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.34. │Òèëîçèí            │Âñå âèäû óáîéíûõ    │Ìÿñî (äëÿ    │0,1       │Êàê òèëîçèí A      

      │Tylosin            │æèâîòíûõ, â òîì     │ðûáû â                                    

      │(ìàêðîëèäû)        │÷èñëå ïòèöà è ðûáà  │íàòóðàëüíîé                               

                         │ïðóäîâàÿ è ñàäêîâîãî│ïðîïîðöèè ñ                               

                         │ñîäåðæàíèÿ          │êîæåé)                                    

                                             │Ïå÷åíü       │0,1                          

                                             │Ïî÷êè        │0,1                          

                                             │Æèð (äëÿ     │0,1                          

                                             │ñâèíåé è                                  

                                             │ïòèöû                                     

                                             │â íàòóðàëüíîé│                             

                                             │ïðîïîðöèè ñ                               

                                             │êîæåé)                                    

                                             │ßéöà         │0,2                          

                                             │Ìîëîêî       │0,05                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.35. │Òèëâàëîçèí         │Ñâèíüè              │Ìÿñî         │0,05      │Ñóììà òèëâàëîçèíà è │

      │Tylvalosin                             │Æèð è êîæà   │0,05      │3-Î-àöåòèëòèëîçèíà 

      │(ìàêðîëèäû)                            │Ïå÷åíü       │0,05                         

                                             │Ïî÷êè        │0,05                         

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ïòèöà               │Ìÿñî         │0,05                         

                                             │Æèð è êîæà   │0,05                         

                                             │Ïå÷åíü       │0,05                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.36. │Òóëàòðîìèöèí       │Êðóïíûé ðîãàòûé     │Æèð          │0,1       │(2R,3S,4R,5R,8R,10R,│

      │Tulathromycin      │ñêîò                │ïå÷åíü       │3         │11R,12S,13S,14R)-2- │

      │(ìàêðîëèäû)                            │ïî÷êè        │3         │ýòèë-3,4,10,13-    

                                                                    │òåòðàãèäðîêñè-3,5,8,│

                         │Ñâèíüè              │Êîæà è æèð   │0,1       │10,12,14-ãåêñàìåòèë-│

                                             │Ïå÷åíü       │3         │11-[[3,4-6-òðèäåîêñè│

                                             │Ïî÷êè        │3         │-3-(äèìåòèëàìèíî)- 

                                                                    │áåòà-Ä-êñèëî-      

                                                                    │ãåêñîïèðàíîñèë]îêñè]│

                                                                    │-1-îêñà-6-         

                                                                    │àçàöèëîïåíòäåêàí-15-│

                                                                    │îäèí, âûðàæåííûé êàê│

                                                                    │ýêâèâàëåíòû        

                                                                    │òóëàòðîìèöèíà      

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.37. │Òèàìóëèí           │Ñâèíüè, êðîëèêè     │Ìÿñî         │0,1       │Ñóììà ìåòàáîëèòîâ, 

      │Tiamulin                               │Ïå÷åíü       │0,5       │êîòîðûå ìîãóò áûòü 

      │(ïëåâðîìóòèëèíû)   ├────────────────────┼─────────────┼──────────┤ãèäðîëèçîâàíû â    

                         │Êóðû                │Ìÿñî         │0,1       │8-àëüôà-           

                                             ├─────────────┼──────────┤ãèäðîêñèìóòèëèí    

                                             │Êîæà è æèð   │0,1                          

                                             ├─────────────┼──────────┤                   

                                             │Ïå÷åíü       │1                            

                                             ├─────────────┼──────────┤                   

                                             │ßéöà è æèäêèå│1                            

                                             │ÿè÷íûå                                    

                                             │ïðîäóêòû                                  

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Èíäåéêè             │Ìÿñî         │0,1                          

                                             ├─────────────┼──────────┤                   

                                             │Êîæà è æèð   │0,1                          

                                             ├─────────────┼──────────┤                   

                                             │Ïå÷åíü       │0,3                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.38. │Âàëüíåìóëèí        │Ñâèíüè              │Ìÿñî         │0,05                         

      │Valnemulin                             ├─────────────┼──────────┤                   

      │(ïëåâðîìóòèëèíû)                       │Ïå÷åíü       │0,5                          

                                             ├─────────────┼──────────┤                   

                                             │ïî÷êè        │0,1                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.39. │Ðèôàêñèìèí/        │Âñå âèäû óáîéíûõ    │ìÿñî         │Ñ         │ðèôàêñèìèí         

      │ðèôàìïèöèí         │æèâîòíûõ, â òîì                  │01.01.2012│                   

      │Rifaximin/         │÷èñëå ïòèöà è ðûáà                                            

      │Rifampicin         │ïðóäîâàÿ è ñàäêîâîãî│                                          

      │(àíñàìèöèíû)       │ñîäåðæàíèÿ                                                    

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Êðóïíûé ðîãàòûé ñêîò│ìîëîêî       │0,06                         

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ï÷åëû               │ìåä          │Ñ                            

                                                          │01.01.2012│                   

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.40. │Êîëèñòèí           │Âñå âèäû óáîéíûõ    │Ìÿñî (äëÿ    │0,15                         

      │ Colistin          │æèâîòíûõ, â òîì     │ðûáû â                                    

      │(ïîëèìèêñèíû)      │÷èñëå ïòèöà è ðûáà  │åñòåñòâåííûõ │                             

                         │ïðóäîâàÿ è ñàäêîâîãî│ïðîïîðöèÿõ ñ │                             

                         │ñîäåðæàíèÿ          │êîæåé)                                    

                                             │Æèð (äëÿ     │0,15                         

                                             │ñâèíåé è                                  

                                             │ïòèöû                                     

                                             │êîæà è æèð â │                             

                                             │åñòåñòâåííûõ │                             

                                             │ïðîïîðöèÿõ)                               

                                             │ïå÷åíü       │0,15                         

                                             │ïî÷êè        │0,2                          

                                             ├─────────────┼──────────┤                   

                                             │Ìîëîêî       │0,05                         

                                             ├─────────────┼──────────┤                   

                                             │ßéöà è æèäêèå│0,3                          

                                             │ÿè÷íûå                                    

                                             │ïðîäóêòû                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.41. │Áàöèòðàöèí         │Êðóïíûé ðîãàòûé ñêîò│ìîëîêî       │0,1       │Ñóììà áàöèòðàöèíîâ 

      │Bacitracin         ├────────────────────┼─────────────┼──────────┤A, B, C, â ò.÷. â  

      │(ïîëèïåïòèäû)      │Êðîëèêè             │Ìÿñî         │0,15      │âèäå öèíê-         

                                             │Æèð          │0,15      │áàöèòðàöèíà        

                                             │Ïå÷åíü       │0,15                         

                                             │ïî÷êè        │0,15                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.42. │Íîâîáèîöèí         │Êðóïíûé ðîãàòûé ñêîò│ìîëîêî       │0,05                         

      │Novobiocin                                                                       

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.43. │Àâèëàìèöèí         │Ñâèíüè,             │Ìÿñî         │0,05      │Äèõëîðîèçî-        

      │Avilamycin         │äîìàøíÿÿ            │Æèð          │0,1       │ýâåðíèíîâàÿ êèñëîòà │

      │(îðòîçîìèöèíû)     │ïòèöà, êðîëèêè      │Ïå÷åíü       │0,3                          

                                             │Ïî÷êè        │0,2                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.44. │Ìîíýíçèí           │Êðóïíûé ðîãàòûé     │Ìÿñî         │0,002     │ìîíåýíçèí A        

      │Monensin           │ñêîò                │Æèð          │0,01                         

      │(èîíîôîðû)                             │Ïå÷åíü       │0,03                         

                                             │Ïî÷êè        │0,002                        

                                             │ìîëîêî       │0,002                        

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ïðî÷èå âèäû óáîéíûõ │Ïå÷åíü       │0,008                        

                         │æèâîòíûõ è ïòèöû,   │Äðóãèå       │0,002                        

                         │êðîìå áðîéëåðîâ,    │ïðîäóêòû                                  

                         │èíäååê                                                        

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.45. │Ëàñàëîöèä          │Ïòèöà               │Ìÿñî         │0,02      │ëàñàëîöèä A        

      │Lasalocid                              │Êîæà è æèð   │0,1                          

      │(èîíîôîðû)                             │Ïå÷åíü       │0,1                          

                                             │Ïî÷êè        │0,05                         

                                             │ÿéöà         │0,15                         

                         ├────────────────────┼─────────────┼──────────┼────────────────────┤

                         │Ïðî÷èå âèäû óáîéíûõ │Ìîëîêî       │0,001     │Íàòðèé ëàñàëîöèä   

                         │æèâîòíûõ, â òîì     │Ïå÷åíü       │0,05                         

                         │÷èñëå ðûáà ïðóäîâàÿ │Ïî÷êè        │0,05                         

                         │è ñàäêîâîãî         │Äðóãèå       │0,005                        

                         │ñîäåðæàíèÿ          │ïðîäóêòû                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.46. │Íèòðîôóðàíû        │Âñå âèäû óáîéíûõ                 │Ñ         │íå äîïóñêàþòñÿ â   

      │(âêëþ÷àÿ           │æèâîòíûõ, â òîì                  │01.01.2012│ïðîäóêöèè æèâîòíîãî │

      │ôóðàçîëèäîí)       │÷èñëå ïòèöà è ðûáà  │Ìÿñî         │< 0,1     │ïðîèñõîæäåíèÿ íà   

      │Nitrofurans        │ïðóäîâàÿ è ñàäêîâîãî│Êîæà è æèð   │< 0,1     │óðîâíå îïðåäåëåíèÿ 

      │(including         │ñîäåðæàíèÿ, ï÷åëû   │Ïå÷åíü       │< 0,1     │ìåòîäîâ            

      │furazolidone)                          │Ïî÷êè        │< 0,1                        

                                             │ÿéöà         │< 0,1                        

                                             │ìîëîêî       │< 0,1                        

                                             │ìåä          │< 0,1                        

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.47. │Ìåòðîíèäàçîë       │Âñå âèäû óáîéíûõ                 │Ñ         │íå äîïóñêàþòñÿ â   

      │(metronidazole)/   │æèâîòíûõ, â òîì                  │01.01.2012│ïðîäóêöèè æèâîòíîãî │

      │äèìåòðèäàçîë       │÷èñëå ïòèöà è       │Ìÿñî                   │ïðîèñõîæäåíèÿ íà   

      │(dimetridazole)/   │ðûáà ïðóäîâàÿ è     │Êîæà è æèð             │óðîâíå îïðåäåëåíèÿ 

      │ðîíèäàçîë          │ñàäêîâîãî           │Ïå÷åíü                 │ìåòîäîâ            

      │(ronidazole)/äàïñîí│ñîäåðæàíèÿ, ï÷åëû   │Ïî÷êè                                     

      │(dapsone)/                             │ÿéöà                                      

      │êëîòðèìàçîë                            │ìîëîêî                                    

      │(clotrimazole)/                        │ìåä                                       

      │àìèíèòðèçîë                                                                      

      │(aminitrizole)                                                                   

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.48. │Ôëàâîìèöèí         │Âñå âèäû óáîéíûõ                 │Äî        │ôëàâîôîñôîëèïîë    

      │Flavomycin         │æèâîòíûõ, â òîì                  │01.01.2012│                   

      │(ñòðåïòîòðèöèíû)   │÷èñëå ïòèöà è ðûáà  │Ìÿñî         │0,7                          

                         │ïðóäîâàÿ è ñàäêîâîãî│Ïå÷åíü       │0,7                          

                         │ñîäåðæàíèÿ, êðåâåòêè│Ïî÷êè        │0,7                          

                                             │Æèð          │0,7                          

                                             │ßéöà         │0,7                          

                                             │Ìîëîêî       │0,7                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.49. │Äîêñèöèêëèí        │Êðóïíûé ðîãàòûé     │Ìÿñî         │0,1                          

      │Doxiciclin         │ñêîò                │Ïå÷åíü       │0,3                          

      │(òåòðàöèêëèíû)                         │Ïî÷êè        │0,6                          

                         ├────────────────────┼─────────────┼──────────┼────────────────────┤

                         │Ñâèíüè, äîìàøíÿÿ    │Ìÿñî         │0,1                          

                         │ïòèöà               │Êîæà è æèð   │0,3                          

                                             │Ïå÷åíü       │0,3                          

                                             │Ïî÷êè        │0,6                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.50. │Áåíçèëïåíèöèëëèí/  │Âñå âèäû óáîéíûõ    │Ìÿñî (äëÿ    │0,05                         

      │ïåíåòàìàò          │æèâîòíûõ, â òîì     │ðûáû â                                    

      │Benzylpenicillin/  │÷èñëå ïòèöà è       │åñòåñòâåííûõ │                             

      │Penethamate        │ðûáà ïðóäîâàÿ è     │ïðîïîðöèÿõ ñ │                             

      │(ãðóïïà            │ñàäêîâîãî ñîäåðæàíèÿ│êîæåé)                                    

      │ïåíèöèëëèíà)                           │Æèð (äëÿ     │0,05                         

                                             │ñâèíåé è                                  

                                             │ïòèöû â                                   

                                             │åñòåñòâåííûõ │                             

                                             │ïðîïîðöèÿõ ñ │                             

                                             │êîæåé)                                    

                                             │Ïå÷åíü       │0,05                         

                                             │Ïî÷êè        │0,05                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.51. │Àìïèöèëëèí         │Âñå âèäû óáîéíûõ    │Ìÿñî (äëÿ    │0,05                         

      │Ampicillin         │æèâîòíûõ, â òîì     │ðûáû â                                    

      │(ãðóïïà            │÷èñëå ïòèöà è       │åñòåñòâåííûõ │                             

      │ïåíèöèëëèíà)       │ðûáà ïðóäîâàÿ è     │ïðîïîðöèÿõ ñ │                             

                         │ñàäêîâîãî ñîäåðæàíèÿ│êîæåé)                                    

                                             │Æèð          │0,05                         

                                             │Ïå÷åíü       │0,05                         

                                             │Ïî÷êè        │0,05                         

                                             │Ìîëîêî       │0,004                        

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.52. │Àìîêñèöèëëèí       │Âñå âèäû óáîéíûõ    │Ìÿñî (äëÿ    │0,05                         

      │Amoxicillin        │æèâîòíûõ, â òîì     │ðûáû â                                    

      │(ãðóïïà            │÷èñëå ïòèöà è       │åñòåñòâåííûõ │                             

      │ïåíèöèëëèíà)       │ðûáà ïðóäîâàÿ è     │ïðîïîðöèÿõ ñ │                             

                         │ñàäêîâîãî           │êîæåé)                                    

                         │ñîäåðæàíèÿ          │Æèð          │0,05                         

                                             │Ïå÷åíü       │0,05                         

                                             │Ïî÷êè        │0,05                         

                                             │Ìîëîêî       │0,004                        

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.53. │Êëîêñàöèëëèí       │Âñå âèäû óáîéíûõ    │Ìÿñî         │0,3                          

      │Cloxacillin        │æèâîòíûõ, â òîì     │Æèð          │0,3                          

      │(ïåíèöèëëèíû)      │÷èñëå ïòèöà è ðûáà  │Ïå÷åíü       │0,3                          

                         │ïðóäîâàÿ è ñàäêîâîãî│Ïî÷êè        │0,3                          

                         │ñîäåðæàíèÿ          │Ìîëîêî       │0,03                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.54. │Äèêëîêñàöèëëèí     │Âñå âèäû óáîéíûõ    │Ìÿñî         │0,3                          

      │Dicloxacillin      │æèâîòíûõ, â òîì     │Æèð          │0,3                          

      │(ïåíèöèëëèíû)      │÷èñëå ïòèöà è ðûáà  │Ïå÷åíü       │0,3                          

                         │ïðóäîâàÿ è ñàäêîâîãî│Ïî÷êè        │0,3                          

                         │ñîäåðæàíèÿ          │Ìîëîêî       │0,03                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.55. │Íàôöèëëèí          │Âñå âèäû æâà÷íûõ    │Ìÿñî         │0,3                          

      │Nafcillin          │æèâîòíûõ            │Æèð          │0,3                          

      │(ïåíèöèëëèíû)                          │Ïå÷åíü       │0,3                          

                                             │Ïî÷êè        │0,3                          

                                             │Ìîëîêî       │0,03                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.56. │Îêñàöèëëèí         │Âñå âèäû óáîéíûõ    │Ìÿñî         │0,3                          

      │Oxacillin          │æèâîòíûõ, â òîì     │Æèð          │0,3                          

      │(ïåíèöèëëèíû)      │÷èñëå ïòèöà è       │Ïå÷åíü       │0,3                          

                         │ðûáà ïðóäîâàÿ è     │Ïî÷êè        │0,3                          

                         │ñàäêîâîãî ñîäåðæàíèÿ│Ìîëîêî       │0,03                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│1.57. │Ôåíîêñèìåòèëïåíè-  │Ñâèíüè              │Ìÿñî         │0,025                        

      │öèëëèí                                 │Ïå÷åíü       │0,025                        

      │Phenoximethylpeni- │                    │Ïî÷êè        │0,025                        

      │cillin             ├────────────────────┼─────────────┼──────────┤                   

      │(ãðóïïà            │Äîìàøíÿÿ ïòèöà      │Ìÿñî         │0,025                        

      │ïåíèöèëëèíà)                           │Êîæà è æèð   │0,025                        

                                             │Ïå÷åíü       │0,025                        

                                             │Ïî÷êè        │0,025                        

└──────┴───────────────────┴────────────────────┴─────────────┴──────────┴────────────────────┘

 

┌──────┬──────────────────────────────────────────────────────────────────────────────────────┐

│2.    │Àíòèïðîòîçîéíûå ñðåäñòâà <**>                                                        

├──────┼───────────────────┬────────────────────┬─────────────┬──────────┬────────────────────┤

│2.1.  │Äèêëàçóðèë         │îâöû                │ìÿñî         │0,5       │êàê äèêëàçóðèë     

      │Diclazuril         │êðîëèêè             │ïå÷åíü       │3,0                          

                                             │ïî÷êè        │2,0                          

                                             │æèð          │1,0                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ïòèöà (öûïëÿòà-     │ìÿñî         │0,5                          

                         │áðîéëåðû, èíäåéêè   │ïå÷åíü       │3                            

                         │äëÿ îòêîðìà), ñâèíüè│ïî÷êè        │2                            

                                            │æèð, êîæà    │1                            

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ïðî÷èå âèäû óáîéíûõ │ßéöà         │0,002                        

                         │æèâîòíûõ, â òîì     │Ïå÷åíü       │0,04                         

                         │÷èñëå ðûáà ïðóäîâàÿ │Ïî÷êè        │0,04                         

                         │è ñàäêîâîãî         │Äðóãèå       │0,005                        

                         │ñîäåðæàíèÿ          │ïðîäóêòû                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.2.  │Èìèäîêàðá          │êðóïíûé ðîãàòûé ñêîò│ìÿñî         │0,3       │êàê èìèäîêàðá      

      │Imidocarb                              │Æèð          │0,05                         

                                             │Ïå÷åíü       │2                            

                                             │Ïî÷êè        │1,5                          

                                             │Ìîëîêî       │0,05                         

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Îâöû                │ìÿñî         │0,3                          

                                             │Æèð          │0,05                         

                                            │Ïå÷åíü       │2                            

                                             │Ïî÷êè        │1,5                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.3.  │Òîëòðàçóðèë        │Âñå âèäû            │Ìÿñî         │0,1       │Òîëòðàçóðèëà       

      │Toltrazuril        │ïðîäóêòèâíûõ        │Æèð          │0,15      │ñóëüôîí            

                         │ìëåêîïèòàþùèõ       │Ïå÷åíü       │0,5                          

                         │Äîìàøíÿÿ ïòèöà      │Ïî÷êè        │0,25                         

                                             │Ìÿñî         │0,1                          

                                            │Êîæà è æèð   │0,2                          

                                             │Ïå÷åíü       │0,6                          

                                             │Ïî÷êè        │0,4                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.4.  │Íèêàðáàçèí         │Öûïëÿòà-áðîéëåðû    │Ìÿñî         │0,2       │êàê N,N'-bis(4-    

      │Nicarbazin                             │Ïå÷åíü       │0,2       │íèòðîôåíèë)        

                                             │Ïî÷êè        │0,2       │ìî÷åâèíà           

                                             │Æèð, êîæà    │0,2                          

                        ├────────────────────┼─────────────┼──────────┤                   

                         │Ïðî÷èå âèäû óáîéíûõ │ßéöà         │0,1                          

                         │æèâîòíûõ, â òîì     │Ìîëîêî       │0,005                        

                         │÷èñëå ðûáà ïðóäîâàÿ │Ïå÷åíü       │0,1                          

                         │è ñàäêîâîãî         │Ïî÷êè        │0,1                          

                         │ñîäåðæàíèÿ          │Äðóãèå       │0,025                        

                                             │ïðîäóêòû                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.5.  │Àìïðîëèóì          │Öûïëÿòà-áðîéëåðû,   │Ìÿñî         │0,2                          

      │Amprolium          │èíäåéêè             │Êîæà è æèð   │0,2                          

                                             │Ïå÷åíü       │0,2                          

                                             │Ïî÷êè        │0,4                          

                                             │ßéöà         │1                            

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.6.  │Ðîáåíèäèí          │Âñå âèäû óáîéíûõ    │ßéöà         │0,025     │Ðîáåíèäèíà         

      │Robenidine         │æèâîòíûõ, ðûáû è    │Ïå÷åíü       │0,05      │ãèäðîõëîðèä        

                        │ïòèöû, êðîìå        │Ïî÷êè        │0,05                         

                         │áðîéëåðîâ, èíäååê è │Êîæà è æèð   │0,05                         

                         │êðîëèêîâ äëÿ îòêîðìà│Äðóãèå       │0,005                        

                                             │ïðîäóêòû                                  

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.7.  │Ñåìäóðàìèöèí       │Âñå âèäû óáîéíûõ    │Âñå âèäû     │0,002                        

      │Semduramicin       │æèâîòíûõ, â òîì     │ïðîäóêòîâ                                 

                         │÷èñëå ðûáà ïðóäîâàÿ │                                          

                        │è ñàäêîâîãî                                                   

                         │ñîäåðæàíèÿ, èñêëþ÷àÿ│                                          

                         │áðîéëåðíûõ öûïëÿò                                             

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.8.  │Íàðàçèí            │Âñå âèäû óáîéíûõ    │ßéöà         │0,002                        

      │Narasin            │æèâîòíûõ, â òîì     │Ìîëîêî       │0,001                        

                         │÷èñëå ðûáà ïðóäîâàÿ │Ïå÷åíü       │0,05                         

                         │è ñàäêîâîãî         │Äðóãèå       │0,005                        

                        │ñîäåðæàíèÿ, èñêëþ÷àÿ│ïðîäóêòû                                  

                         │áðîéëåðíûõ öûïëÿò                                             

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.9.  │Ìàäóðîìèöèí        │Âñå âèäû óáîéíûõ    │Âñå âèäû     │0,002                        

      │Maduramicin        │æèâîòíûõ, â òîì     │ïðîäóêòîâ                                 

                         │÷èñëå ðûáà ïðóäîâàÿ │                                          

                         │è ñàäêîâîãî                                                   

                         │ñîäåðæàíèÿ, èñêëþ÷àÿ│                                          

                        │áðîéëåðíûõ öûïëÿò è │                                          

                         │èíäååê                                                        

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.10. │Ñàëèíîìèöèí        │Âñå âèäû óáîéíûõ    │Ïå÷åíü (çà   │0,005     │Salinomycin sodium 

      │Salinomycin        │æèâîòíûõ, â òîì     │èñêëþ÷åíèåì                               

                         │÷èñëå ïòèöà, ðûáà   │êðîëè÷üåé)                                

                         │ïðóäîâàÿ è ñàäêîâîãî│ßéöà         │0,003                        

                         │ñîäåðæàíèÿ, èñêëþ÷àÿ│Äðóãèå       │0,002                        

                        │áðîéëåðíûõ öûïëÿò è │ïðîäóêòû                                  

                         │êðîëèêîâ äëÿ îòêîðìà│                                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.11. │Ãàëîôóãèíîí        │Âñå âèäû óáîéíûõ    │Ìÿñî         │0,01                         

      │Halofuginone       │æèâîòíûõ, â òîì     │Æèð è êîæà   │0,025                        

                         │÷èñëå ïòèöà, ðûáà   │Ïå÷åíü       │0,03                         

                         │ïðóäîâàÿ è ñàäêîâîãî│Ïî÷êè        │0,03                         

                         │ñîäåðæàíèÿ, èñêëþ÷àÿ│ßéöà         │0,006                        

                        │áðîéëåðíûõ öûïëÿò,  │Ìîëîêî       │0,001                        

                         │èíäååê è êðóïíûé    │Äðóãèå       │0,003                        

                         │ðîãàòûé ñêîò, êðîìå │ïðîäóêòû                                  

                         │ìîëî÷íîãî                                                     

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│2.12. │Äåêîêâèíàò         │Âñå âèäû óáîéíûõ    │Âñå âèäû     │0,02                         

      │Decoquinate        │æèâîòíûõ, â òîì     │ïðîäóêòîâ                                 

                         │÷èñëå ïòèöà, ðûáà                                             

                         │ïðóäîâàÿ è ñàäêîâîãî│                                          

                         │ñîäåðæàíèÿ, èñêëþ÷àÿ│                                          

                         │áðîéëåðíûõ öûïëÿò,                                            

                         │êðóïíûé è ìåëêèé                                              

                         │ðîãàòûé ñêîò, êðîìå │                                          

                         │ìîëî÷íîãî                                                     

└──────┴───────────────────┴────────────────────┴─────────────┴──────────┴────────────────────┘

 

┌─────────────────────────────────────────────────────────────────────────────────────────────┐

│3. Èíñåêòèöèäû <**>                                                                         

├──────┬───────────────────┬────────────────────┬─────────────┬──────────┬────────────────────┤

  1            2                 3                4          5              6         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│3.1.  │Öèãàëîòðèí         │êðóïíûé ðîãàòûé     │ìÿñî         │0,02      │êàê öèãàëîòðèí      

      │Cyhalothrin        │ñêîò, ñâèíüè, îâöû  │ïå÷åíü       │0,02                         

                                             │ïî÷êè        │0,02                         

                                             │æèð          │0,4                          

                                                                                       

                         │êðóïíûé ðîãàòûé ñêîò│ìîëîêî       │0,03                         

                                                                                      

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│3.2.  │Äèöèêëàíèë         │îâöû                │ìÿñî         │0,2       │Ñóììà äèöèêëàíèëà è │

      │Dicyclanil                             │ïå÷åíü       │0,4       │2,4,6-òðèàìèíî-    

                                             │ïî÷êè        │0,4       │ïèðèìèäèí-5-       

                                             │æèð          │0,15      │êàðáîíèòðèëà       

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│3.3.  │Òðèõëîðôîí         │êðóïíûé ðîãàòûé ñêîò│ìîëîêî       │0,05      │êàê òðèõëîðôîí     

      │Trichlorfon                                                                      

      │(Metrifonate)                                                                    

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│3.4.  │Äåëüòàìåòðèí       │êðóïíûé ðîãàòûé     │ìÿñî         │0,03      │êàê äåëüòàìåòðèí   

      │Deltamethrin       │ñêîò, îâöû, êóðû    │ïå÷åíü       │0,05                         

                                             │ïî÷êè        │0,05                         

                                             │æèð          │0,5                          

                                                                                       

                         │êðóïíûé ðîãàòûé ñêîò│ìîëîêî       │0,03                         

                         │êóðû                │ÿéöà         │0,03                         

                         │ðûáà (ëîñîñü)       │ìÿñî         │0,03                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│3.5.  │Ôîêñèì             │îâöû, êîçû          │ìÿñî         │0,05      │êàê ôîêñèì         

      │Phoxim                                 │ïå÷åíü       │0,05                         

                                             │ïî÷êè        │0,05                         

                                             │æèð          │0,4                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │ñâèíüè              │Ìÿñî         │0,02                         

                                             │Êîæà è æèð   │0,7                           

                                             │Ïå÷åíü       │0,02                         

                                             │Ïî÷êè        │0,02                         

                         ├────────────────────┼─────────────┼──────────┤                   

                         │êóðû                │Ìÿñî         │0,025                        

                                             │Êîæà è æèð   │0,55                         

                                             │Ïå÷åíü       │0,05                         

                                             │Ïî÷êè        │0,03                         

                                             │ßéöà         │0,06                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│3.6.  │Öèôëóòðèí          │êðóïíûé ðîãàòûé     │Ìÿñî         │0,01      │êàê öèôëóòðèí      

      │Cyfluthrin         │ñêîò, êîçû          │Æèð          │0,05      │(ñóììà èçîìåðîâ)   

                                             │Ïå÷åíü       │0,01                         

                                             │Ïî÷êè        │0,01                         

                                             │Ìîëîêî       │0,02                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│3.7.  │Öèïåðìåòðèí è      │Âñå æâà÷íûå         │ìÿñî         │0,02      │Öèïåðìåòðèí (ñóììà 

      │àëüôà-öèïåðìåòðèí                      │Æèð          │0,2       │èçîìåðîâ)          

      │Cypermethrin a.                        │Ïå÷åíü       │0,02                         

      │Alpha-Cypermethrin │                    │Ïî÷êè        │0,02      │Ìûøöû è êîæà ðûáû â │

                                             │Ìîëîêî       │0,02      │åñòåñòâåííûõ       

                         ├────────────────────┼─────────────┼──────────┤ïðîïîðöèÿõ         

                         │Ëîñîñåâûå           │ìÿñî         │0,05                         

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│3.8.  │Ôëóàçóðîí          │êðóïíûé ðîãàòûé ñêîò│ìÿñî         │0,2                          

      │Fluazuron                              │ïå÷åíü       │0,5                          

                                             │ïî÷êè        │0,5                          

                                             │æèð          │7,0                          

├──────┼───────────────────┼────────────────────┼─────────────┼──────────┼────────────────────┤

│3.9.  │Àìèòðàç            │Êðóïíûé ðîãàòûé ñêîò│Æèð          │0,2       │Ñóììà àìèòðàçà è   

                                             │Ïå÷åíü       │0,2       │âñåõ ìåòàáîëèòîâ,  

                                             │Ïî÷êè        │0,2       │ñîäåðæàùèõ 2,4-    

                                             │Ìîëîêî       │0,01      │äèìåòîêñèàì ôåòàìèí │

                         ├────────────────────┼─────────────┼──────────┤(2,4-DMA) ãðóïïó,  

                         │Îâöû                │Æèð          │0,4       │âûðàæåííàÿ êàê     

                                             │Ïå÷åíü       │0,1       │àìèòðàç            

                                             │Ïî÷êè        │0,2                          

                                             │Ìîëîêî       │0,01                         

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Êîçû                │Æèð          │0,2                          

                                             │Ïå÷åíü       │0,1                          

                                             │Ïî÷êè        │0,2                          

                                             │Ìîëîêî       │0,01                         

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ñâèíüè              │Êîæà è æèð   │0,4                          

                                             │Ïå÷åíü       │0,2                          

                                             │Ïî÷êè        │0,2                          

                         ├────────────────────┼─────────────┼──────────┤                   

                         │Ï÷åëû               │ìåä          │0,2                          

└──────┴───────────────────┴────────────────────┴─────────────┴──────────┴────────────────────┘

 

--------------------------------

Ïðèìå÷àíèå:

<*> Ìàêñèìàëüíûå óðîâíè îñòàòêîâ àíòèìèêðîáíûõ ñðåäñòâ äëÿ æèðà, ïå÷åíè è ïî÷åê íå ïðèìåíÿþòñÿ ê ðûáå.

<**> Êîíòðîëü âñåõ ïðåïàðàòîâ, âêëþ÷åííûõ â èíäåêñ 1 "Àíòèìèêðîáíûå ñðåäñòâà", çà èñêëþ÷åíèåì ñòðåïòîìèöèíà/äèãèäðîñòðåïòîìèöèíà, âåùåñòâ ñóëüôàíèëàìèäíîé ãðóïïû (ñóëüôàíèëàìèäîâ), àíòèáèîòèêîâ òåòðàöèêëèíîâîé ãðóïïû, áàöèòðàöèíà â ìÿñå, ïå÷åíè, ïî÷êàõ, ãðóïïû ïåíèöèëëèíà, èíäåêñ 2 "Àíòèïðîòîçîéíûå ñðåäñòâà", èíäåêñ 3 "Èíñåêòèöèäû" - ñ ìîìåíòà óòâåðæäåíèÿ ìåòîäîâ îïðåäåëåíèÿ.".